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CHAPTER I. INTRODUCTION 
Acyl-CoA Cholesterol Acyltransferase (ACAT) (EC.2.3.1.26) catalyzes intracellular 
esterification of cholesterol with long chain fatty acyl Coenzyme A. ACAT is an integral 
membrane protein and resides in the cytoplasmic side of the rough endoplasmic reticulum 
[1]. ACAT activity has been observed in many different kinds of tissues and plays a very 
important role in the maintenance of intracellular cholesterol homeostasis. In the liver, the 
production and secretion of lipoproteins, which deliver various lipid molecules to peripheral 
tissues, require a lipid core of triacylglycerols and cholesteryl esters. Dietary absorption 
of cholesterol requires the function of intestinal ACAT, which controls the rate-limiting step 
of absorption [2]. Overaccumulation of cholesteryl esters in macrophages and smooth 
muscle cells in large arteries leads to formation of fatty streaks and atherosclerosis. 
Despite its biological significance, ACAT has not been isolated and studied in 
purity. M. Shih has reported the observation of a sigmoidal relationship between the 
enzymatic activity and cholesterol mole fraction in the liposomes when she studied mouse 
liver microsomal ACAT [3]. In her work, the enzyme was extracted with 1.5% 
deoxycholate-1 N KCl and reconstituted into cholesterol-PC liposomes. In 1993, T.Y. 
Chang and coworkers made a major breakthrough in ACAT research and cloned a human 
macrophage enzyme that had ACAT activity [4]. Expression of the cDNA in insect Sf9 
cells, which lack intrinsic ACAT activity and have very low intracellular cholesterol, 
allowed Chang et al [5] to study the enzyme at the molecular level. By using the formation 
of ^H-25-hydroxycholesteryl oleate as the way to measure ACAT activity, they found that 
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the human enzyme is activated by cholesterol through a cooperative mechanism [5]. Thus, 
in mammalian cells, cholesterol serves as an allosteric activator as well as a substrate of 
ACAT. 
A high profile of cholesterol esterification was observed in the yolk sac membrane 
of fertilized chicken eggs by J.H. Shand et al [6] during their study of lipid metabolism in 
chick embryos. The importance of cholesteryl esters in the formation and secretion of 
lipoproteins in the yolk sac membrane is understood as part of the supply of nutrients to 
serve as structural components and energy source for the developing embryos [7]. More 
than 5 fold higher ACAT activity was observed at day 16 in the yolk sac membrane 
compared with that in the liver or intestine [6]. 
Cyclodextrins are a family of cyclic molecules composed of different number of 
glucose units. Among the commercially available cyclodextrins, P-cycIodextrin and its 
derivatives have been found to be the most efficient molecules to extract cholesterol from 
lipid bilayers [8,9]. A complex of cholesterol with methyl-P-cyclodextrin can be used as 
an efficient delivery tool to provide cells or other biological systems with cholesterol [10]. 
In the present work, microsomes of the yolk sac membrane fi-om chicken eggs 16 
days after fertilization were used to characterize ACAT. Because of its vital role in embryo 
development and the much higher specific activity of ACAT, the yolk sac membrane 
provided a better system for the study of the enzyme, and any information learned from the 
avian enzyme could be useful in the understanding of its mammalian counterpart. The 
property of the yolk sac membrane enzyme was compared to the mammalian equivalent 
with regard to chemical modification and regulation of activity by (oxy)sterols. Methyl-P-
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cyclodextrin was used to deplete microsomes of cholesterol and was found to be very 
important in enhancing substrate access to the enzyme. 
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CHAPTER n. LITERATURE REVIEW 
A. Biological Functions of ACAT 
Cholesterol is an essential structural component of mammalian plasma membrane. 
It induces ordered and tighter packing of the lipid bilayer and reduces the permeability of 
the membrane to small molecules [11]. As the precursor of steroid hormones and bile 
acids, cholesterol plays an important part in steroidogenesis and dietary fat absorption. 
Recently, the importance of cholesterol in embryo development was illustrated by the 
finding of covalent modification of the secreted signaling molecule Hedgehog by 
cholesterol and the modification was vital for the normal function of the key patterning 
molecule during embryogenesis [12]. However, the amount of free cholesterol inside the 
cell has to be regulated within certain levels, and a higher concentration of free cholesterol 
is detrimental to normal cellular functions. Culturing macrophages in the presence of 
acetyl-LDL or ACAT inhibition by specific ACAT inhibitors resulted in elevations in 
intracellular free cholesterol, which in turn caused cellular necrosis and cell death [13,14]. 
Enrichment of cholesterol in whole cells or membrane preparations inhibited several 
membrane-bound enzymes, including (Na"" + K'^)-ATPase, calcium pump, alkaline 
phosphatase, and carnitine palmitoyltransferase [15-18]. Alteration in cellular cholesterol 
content affected the development and function of tight jxmctions in epithelial barriers [19]. 
The cell, therefore, employs very sophisticated mechanisms to keep the amount of free 
cholesterol within a certain range. 
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The two rate-limiting enzymes in de novo biosynthesis of cholesterol, 3-hydroxy-3-
methylglutaryl-CoA (HMG-CoA) synthase and HMG-CoA reductase are subjects of sterol-
mediated feedback control [20,21]. The cellular content of free cholesterol regulates the 
amounts of the enzymes at the transcriptional level through sterol regulatory element 
binding proteins, and the activity of the reductase is controlled at the post-transcriptional 
level as well, through protein synthesis and degradation. Cholesterol derived exogenously 
through the low density lipoprotein (LDL) pathway [22] suppresses the activities of the 
synthase and reductase and is subjected to sterol-mediated feedback control via the LDL 
receptor at the transcriptional level in a similar fashion as the other two enzymes [20,21]. 
ACAT functions in converting excess free cholesterol to cholesterol esters and, 
together with HMG-CoA synthase, HMG-CoA reductase, and the LDL receptor, 
maintaining a near constant and low intracellular concentration of free cholesterol. When 
the cellular cholesterol content rises, through either stimulated de novo synthesis or 
increased uptake of exogenous cholesterol, ACAT activity is elevated and cholesterol ester 
synthesis is increased. Cholesterol loading of cultured cells, both primary and cell lines, 
stimulates ACAT activity in many different cell types [23]. Dietary feeding of whole 
animals with cholesterol increases ACAT activity in the livers and intestines of many 
different animals, including rat, rabbit, hamster, and guinea pig (reviewed by Suckling and 
Stange [1]). As the storage form of free cholesterol, cholesteryl esters are not inert but 
undergo a constant cycle of hydrolysis, catalyzed by cholesteryl ester hydrolase, and re-
esterification, catalyzed by ACAT, and depending on the cellular requirement of free 
cholesterol, both enzymes can be activated or inhibited through mechanisms that are still 
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not quite clear and are under active investigation. There is a cytosolic protein inhibitor of 
the neutral cholesteryl ester hydrolase and the inhibitor activity is regulated by 
physiological, hormonal, and nutritional factors [24,25]. Understanding of the mechanisms 
controlling ACAT activity has been accelerated by the cloning of the human cDNA [4] and 
will be discussed in detail in a section on regulation of ACAT activity. Accumulation of 
cholesteryl esters inside the cell leads to the formation of cytosolic lipid droplets. 
Besides the important function in regulating cholesterol homeostasis inside the cell, 
ACAT plays a special role in the production and secretion of lipoproteins in the liver. 
Whole animal experiments showed that a diet of high cholesterol content increased hepatic 
esterified cholesterol 4.6 fold and LDL-cholesterol 7 fold in adult male monkeys [26] and 
feeding miniature pigs for 21 days with a diet containing an ACAT inhibitor inhibited 
hepatic microsomal ACAT and decreased VLDL and LDL apoB pool sizes [27]. The 
decreases in VLDL and LDL apoB pool sizes were due to decreases in the rates of 
lipoprotein production and secretion. When the livers were isolated from Afncan green 
monkeys and perfused with a mediimi containing ACAT inhibitors, significant reductions 
in the rates of secretion of cholesteryl ester and apoB were observed and the correlation 
between the percent inhibition of cholesteryl ester secretion and of apoB secretion was 
positive (r = 0.84) [28]. An experiment in vitro with the human hepatoma cell line 
(HepG2) showed that a specific ACAT inhibitor inhibited cholesteryl ester formation and 
apoB secretion concomitantly, and activation of ACAT by 25-hydroxycholesterol elevated 
cholesteryl ester content and lipoprotein secretion [29]. A coordinated regulation of 
cholesteryl ester synthesis and lipoprotein assembly and secretion in the liver is the working 
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model currently proposed [28]. AC AT inhibitors have been sought enthusiastically by the 
pharmaceutical industry, aiming at reducing the secretion of lipoproteins and cholesteryl 
esters into the blood stream. 
Bile salts, derived from cholesterol in the liver, function as detergents to facilitate 
the digestion and absorption of dietary lipids in the intestine. The secretion of bile salts 
in the liver is found to be inversely correlated with the formation of cholesteryl esters and 
hepatic ACAT activity, as demonstrated by an ACAT inhibition experiment in male rats 
[1]. Thus, in the liver, the flow of cholesterol, either to bile salt production or cholesteryl 
ester formation, is tightly controlled by physiological requirements through the rate-limiting 
en2ymes cholesterol-7a-hydroxylase and ACAT. 
The requirement of apoB-containing lipoproteins in embryonic development was 
demonstrated by an apoB knockout experiment in which mouse embryos with 
homozygously disrupted apoB gene were found to be not viable and most of them were 
resorbed during early stages of gestation [30]. ApoB-containing lipoproteins secreted from 
the yolk sac membrane provide essential lipid nutrients to serve as structxiral components 
and energy source for the developing embryos in avian as well as marrunalian systems 
[7,31]. Experiments with chicken embryos indicated that cholesteryl esters were 
synthesized extensively, about 80% of the free cholesterol was converted to cholesteryl 
esters, in the yolk sac membrane and the esters were very important in the assembly and 
stability of lipoproteins secreted into embryonic circulation [7]. Esterification of 
cholesterol, which exists primarily as the free sterol in the yolk, facilitates the absorption 
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of fatty acids as well as cholesterol and contributes importantly to the absorption and 
transportation of lipid from yolk to embryos [7]. 
For intact animals, cholesterol can be derived from two different sources: de novo 
biosynthesis and dietary absorption. For an average-sized human, dietary uptake of 
cholesterol is between 300 and 500 mg daily and endogenous biosynthesis gives rise to 700 
to 900 mg per day [2]. Studies showed that the site of cholesterol absorption in the 
intestine correlates with the longitudinal distribution of ACAT activity [1]. To be absorbed 
into the body, dietary cholesteryl esters have to be hydrolyzed, by pancreatic cholesteryl 
ester hydrolase, to the free sterol before being taken up by the villous cells. ACAT 
facilitates cholesterol absorption by catalyzing the formation of cholesteryl esters which are 
incorporated into chylomicrons prior to entering lymphatics. In fact, the rate-limiting step 
of cholesterol absorption lies at the activity of intestinal ACAT and inhibition of this 
enzyme reduces dietary uptake of the sterol and increases secretion into feces [1,2]. 
Experiments in vivo indicated that reduction in cholesterol absorption by inhibition of 
intestinal ACAT has a far-reaching effect on lowering plasma total cholesterol [1,2]. 
Steroid hormone-producing tissues meet their cholesterol need primarily through 
uptake of plasma lipoproteins; de novo synthesis of cholesterol only plays a minor part [1]. 
After getting into the cell, lipoproteins are delivered and hydrolyzed in lysosomes. Free 
cholesterol released from lysosomes is converted into esters by ACAT, and cholesteryl 
esters are stored and used for future steroid hormone synthesis. With changes in the rates 
of exogenous absorption and steroidogenesis, the content of cellular cholesteryl esters can 
fluctuate 20 fold without affecting the level of free cholesterol [32]. 
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The early stage of atherosclerosis is characterized by the formation in the subintimal 
space of fatty streaks which consist of lipid, mainly cholesteryl esters, deposits along blood 
vessel walls. The uptake of modified LDL through the scavenger receptor by macrophages 
is not subjected to feedback control, as is the LDL pathway, and leads to massive 
accumulation of cholesteryl esters and foam cell formation. Inhibition of aortic ACAT 
activity can reduce cholesteryl ester synthesis and enhance reverse cholesterol transport to 
the liver for clearance, through high density lipoprotein and lecithin cholesterol 
acyltransferase. Regression of fatty lesions has been observed in animals treated with 
cholesterol-lowering drugs or low cholesterol diet [33]. There has been an extensive effort 
from pharmaceutical companies to search for ACAT inhibitors and a variety of compounds, 
ranging from tranquilizers and antihypertensives to antifungals and steroids [2], have been 
found to inhibit ACAT activity to various degrees both in vitro and in vivo. Presumably, 
ACAT inhibitors could interfere with dietary cholesterol uptake in intestine, synthesis and 
secretion of cholesteryl ester and lipoprotein in the liver, or accumulation of cholesteryl 
esters along blood vessel walls, or all of them. The study of ACAT structure and 
understanding of enzyme catalysis and regulation will surely be very useful in helping to 
design and produce ACAT inhibitors to prevent and cure atherosclerosis in the fliture. 
B. Structure and Molecular and Biochemical Studies of ACAT 
Because of extreme sensitivity towards detergents and the minute quantity in tissues 
of this enzyme, ACAT has not been isolated and purified to homogeneity, only partial 
purification of the protein was achieved with the use deoxycholate for solubilization 
followed by ammonium acetate precipitation and Sepharose 4B column chromatography 
[34]. Most of the studies of this protein use microsomal preparations from tissues of 
different sources. A major breakthrough was made when Chang and his coworkers cloned 
and expressed a human macrophage cDNA, the protein product of which has ACAT 
activity, in mutant Chinese Hamster Ovary (CHO) cells [4]. Those mutant cells lack 
intrinsic ACAT activity. The cDNA has 1650 base pairs and codes for an integral 
membrane protein of 550 amino acids and 64, 805 dalton. In the primary sequence, 5 
segments have high hydrophobicity and two of them are potential transmembrane a helices. 
The deduced protein bears high sequence homology with human acyl-CoA synthetase and 
firefly luciferase, both of which function in acyl thiolation and acyl transfer. Previous 
experiments using radiation inactivation estimated the functional size of rat liver ACAT to 
be 170-180 kDa [35] and 213 ± 35 kDa [36]. In the deduced protein sequence of the 
human ACAT, there is a varied version of the leucine heptad motif which is a signal for 
protein dimerization. It is possible that the protein oligomerizes under physiological 
conditions and might function as an oligomer. There are 9 cysteines in the polypeptide, 
none of them in close vicinity to the others in the primary sequence. Purification of ACAT 
has been attempted for many years in Chang's lab and in others, success, however, has not 
been achieved, even with the cloning of the human cDNA and all the structural information 
learned thereafter, and the extensive exploitation of the powerful techniques of molecular 
biology [23]. Failure to transform bacterial cells with ACAT-containing vectors is probably 
part of the reason for unsuccessful trials [4], unique properties and structural features of the 
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enzyme and die particular microenvironment necessary around it must be major factors 
hampering the achievement of a homogenous protein. Study of ACAT is, by now^, still 
restricted to microsomal preparations or detergent solubilized extracts, and immimological 
analysis of the protein can only be done using antibodies raised against short synthetic 
peptides deduced from the cDNA sequence or a chimeric protein consisting of part of the 
predicted ACAT sequence fused to bacterial glutathione S-transferase [5,37]. 
At about the same time when Chang et al made their success in cloning human 
ACAT [4], another group claimed identification of a porcine liver protein that had 
cholesterol esterification activity and found the sequence of the protein to be identical to 
that of liver carboxylesterase [38]. Using molecular biology techniques, they were able to 
identify a human liver cDNA clone and expressed it in CHO cells. The expression of the 
clone led to a 20 fold increase in cellular cholesteryl ester synthesis and a near 3 fold 
elevation in ACAT activity. The nucleic acid sequence of the clone was found to be 
identical to that of human liver carboxylesterase. Having apparent ACAT activity, the 
sequence of this enzyme bears no homology with that reported by Chang et al [4] and the 
discrepancy awaits further investigation. 
By use of the human cDNA as a probe and fluorescence in situ hybridization 
technique, Chang and his colleagues located the ACAT gene of their clone to human 
chromosome 1, band q25 [39]. By a similar approach, Chang et al isolated a cDNA of 
ACAT from mouse liver and found 87% identity between the deduced protein sequences 
of the human and mouse counterparts [40]. The predicted protein from mouse liver has 
540 amino acids, at least two potential transmembrane a helices, a leucine heptad motif. 
12 
and sequences homologous to those found in proteins functioning in acyl thiolation and 
acyl transfer [40]. 
Two yeast genes encoding for ACAT-related enzymes were discovered [41], and the 
predicted protein sequences were 23% identical to the human protein [4]. The yeast 
proteins are predicted to have at least two transmembrane domains and a leucine zipper 
motif, similar to the human protein. Both of the genes had to be disabled to have a 
complete abolishment of sterol esterification in the yeast [41]. 
A rabbit liver ACAT cDNA was cloned and found to be more than 90% 
homologous to the human equivalent [42]. More than six mRNA bands, ranging from 1.7 
to 6.2 kb, were shown on the Northern blot using a liver cDNA-derived RNA as the probe 
and mRNAs from different rabbit tissues. The possibility that tissues have different 
mRNAs, probably due to alternative splicing, and therefore, different isoforms of ACAT 
was implied. 
ACAT-knockout mice were generated using human ACAT cDNA [4] as a probe and 
gene targeting in mouse embryonic stem cells [43]. Decreased cholesterol esterification 
was observed in adrenal glands, fibroblasts, and macrophages of the mutant mice, but a 
similar level of cholesterol esterification activity as in wild-type mice and substantial 
amounts of cholesteryl esters were observed in the liver. ACAT gene disruption did not 
affect dietary uptake of cholesterol and the mutant mice had a healthy phenotype. The 
result suggests that in mouse other undiscovered cholesterol esterification enzymes, the 
genes of which are different from the gene targeted in the gene-disruption experiment, may 
exist and function redundantly in the liver and intestine. 
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Biochemical studies of ACAT were performed using microsomal preparations from 
different organs of white New Zealand male rabbits [44]. Inhibition experiments using 
diethyl pyrocarbonate and acetic anhydride implicated a histidine residue in the active site 
and possible participation of the histidine in catalysis [44]. Based on the sensitivity of the 
histidine toward DEPC and acetic anhydride, two distinct subtypes of ACAT were 
identified among the 14 tissues tested. The aortic enzyme, representing one subtype, had 
apparent Ki's of 40 (J.M and 500 jiM for DEPC and acetic anhydride, respectively, while 
the liver ACAT, representing the other subtype, had Ki's of 1500 and 5 mM, 
respectively. 
At least two sulfhydryls were identified in microsomal ACAT from white New 
Zealand male rabbits and modification of them with thiol-reactive agents affected the 
enzymatic activity [45]. Experiments with p-hydroxymercuribenzoate and protection 
against PMB modification by oleoyl-CoA indicated that one sulfliydryl was necessary for 
catalysis, and the other was near an inhibitory Co A binding site [45]. 
One serine residue was shown to be essential for the catalysis of cholesterol 
esterification in Chinese hamster ovary cells [46]. SRD-4 cells are mutant CHO cells that 
lack intrinsic ACAT activity. Wild-type and mutant ACAT cDNAs were cloned and 
sequence comparison indicated a single point mutation in the mutant ACAT, codon 265 is 
changed from Ser to Leu. The single mutation results in an inactive enzyme. 
In plasma, cholesterol esterification is catalyzed by lecithin cholesterol 
acyltransferase (LCAT), an enzyme that associates with high density lipoprotein and uses 
phosphatidylcholine as the acyl donor. The protein has been purified to homogeneity and 
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structural and mechanistic information is known in detail. The typical active-site triad 
composed of a serine, histidine, and aspartate, has been identified to function m catalysis 
of cholesteryl ester formation [47]. Previous studies of LCAT had suggested the 
involvement of two cysteine residues in catalysis [48], site-directed mutagenesis of the two 
cysteines, however, gave a fully active enzyme [49,50]. It turns out that the cysteine 
residues do not participate in the catalytic activity, but their location in the vicinity of the 
active site poses a steric hindrance to substrate binding upon modification of the sulfhydryls 
by thiol-blocking agents [49,50]. Considering the similar enzymatic flmction of AC AT and 
LCAT, the two enzymes may share many common mechanistic features, and the knowledge 
learned about LCAT may be useful in the exploration of structure and catalytic mechanism 
of ACAT. 
C. Regulation of ACAT Activity 
Studies of ACAT in rat liver microsomes have indicated that the optimal condition 
for cholesterol esterification is around 37°C and neutral pH [51]. The rat liver enzyme has 
a preference for oleoyl CoA as the acyl donor, but it can utilize other acyl CoAs as well 
[52]. ACAT activity exhibits a cycle of diurnal rhythm with maximal and minimal 
activities at mid-light and mid-dark phases, respectively [53]. Other enzymes involved in 
cholesterol metabolism, i.e., HMG-CoA reductase, cholesteryl ester hydrolase, and the LDL 
receptor also show cycles of diurnal variation, with different maximum and minimum 
activity phases. The concentration of cholesteryl esters parallels the change in the enzyme 
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activity, but on the contrary, the cellular free cholesterol level stays about the same during 
the entire cycle [53]. 
The possibility that ACAT activity is regulated through reversible phosphorylation 
was examined in the macrophage cell line J774.2 and male Wistar rat liver [54]. 
Experimental evidence did not support the hypothesis that ACAT activity was modulated 
through phosphorylation-dephosphorylation, even though other enzymes involved in 
cholesterol metabolism, e.g. HMG-CoA reductase, are regulated this way. Sequence 
examination of human macrophage ACAT cDNA can not identify any consensus 
phosphorylation site in the protein [4], consistent with the biochemical study [54]. 
A short-lived protein factor that inhibits ACAT activity endogenously inside the cell 
was first proposed by Chang et al when they studied cholesterol esterification in Chinese 
Hamster Ovary cells [55,56]. When the cells were treated with the protein synthesis 
inhibitor cycloheximide, a 8 fold increase in ACAT activity was observed and the increase 
reached a maximum in 6-8 hours. When the cells were provided with cholesterol 
exogenously through LDL or endogenously through de novo synthesis, cholesteryl ester 
synthesis was elevated and the cycloheximide sensitive activation of ACAT was abolished. 
The possible existence of the short-lived protein inhibitor of ACAT in the cell was 
confirmed by experiments conducted by I. Tabas and G. Boykow with mouse peritoneal 
macrophages [57]. In the experiment, treatment of the macrophages with cycloheximide 
led to a 10 fold activation of ACAT within 4 hours and withdrawal of cycloheximide led 
to return of the activity to control level in 4 hours. When mouse peritoneal macrophages 
or CHO cells were treated with two structurally different cysteine protease inhibitors. 
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ALLN or epoxysuccinyIleucyIamido-3-methylbutane ethyl ester, the sterol-stimulated 
cholesterol esterification was diminished [58]. Based on previous observation and other 
experimental evidence, Tabas et al proposed a proteolysis/inhibitor pathway that, together 
with the controls in HMG-CoA synthase, HMG-CoA reductase, and the LDL receptor, 
regulates the level of free cholesterol and cholesterol esterification in the cell [58]. In the 
pathway, expansion of the cellular sterol pool, through either endogenous or exogenous 
supply of cholesterol, activates a set of cysteine proteases which then cleave and inactivate 
the intrinsic ACAT inhibitor. The destruction of the inhibitor allows a frill activation of 
ACAT, resulting in an increased synthesis of cholesterol esters. The net result of this is 
a reduced level of cellular free cholesterol, preventing any toxic effect of free cholesterol 
to the cell [58]. 
Many studies have shown that under physiological conditions, ACAT is not 
saturated with cholesterol and addition of cholesterol directly or through lipoproteins or 
liposomes to whole cells or microsomes can activate ACAT substantially [1,59]. 
Cholesterol oxidase susceptibility indicates that about 90% of cellular free cholesterol is 
associated with the plasma membrane with the rest distributed in intracellular membrane 
systems [60]. Transfer of the sterol from other cellular fractions to the ACAT substrate 
pool, therefore, can be a limiting factor [1]. Lipid molecules such as progesterone and 
sphingomyelin have been shown to affect cholesterol esterification by affecting accessibility 
of the sterol to the enzyme substrate pool [61-69]. 
Progesterone was shown to inhibit microsomal ACAT activity from rat liver, and 
the inhibition was not due to a direct effect on en2:yme catalysis [61]. Fluorescent staining 
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of fibroblasts revealed extensive accumulation of free cholesterol in lysosomes when the 
cells were cultured in the presence of LDL and progesterone for 24 hours [62]. Reduced 
cholesteryl ester synthesis was observed along with the lysosomal sterol accumulation. 
Removal of progesterone from the cell culture reduced the amount of accumulated free 
cholesterol in lysosomes and increased ACAT activity and cholesterol ester synthesis [62]. 
The result indicates that progesterone affects ACAT activity indirectly, by sequestering the 
sterol in lysosomes, therefore, limiting the enz3ane access to the substrate [62]. 
Distribution of sphingomyelin in the cell is very similar to that of cholesterol, with 
the majority of the lipid molecule located in the plasma membrane and the minority in 
intracellular membranes [63]. Despite the distinct structural differences, sphingomyelin and 
cholesterol are shown to interact strongly with each other in membranes and concentrations 
of the two lipids are related closely and positively. The hydrogen bond between the NH 
group of sphingomyelin and the hydroxy group of cholesterol and van der Waals 
interactions between these two allow a tight lateral packing between the two molecules and 
high cohesion energy in membranes containing sphingomyelin and cholesterol [64,65]. 
When fibroblasts or macrophages were treated with SMase, hydrolysis of sphingomyelin 
was accompanied by a loss of cholesterol in the plasma membrane with a concomitant 
increase in cellular esterified cholesterol and ACAT activity [63,66,67]. SMase treatment 
of fibroblasts inhibited endogenous biosynthesis of cholesterol and HMG-CoA reductase 
activity as examined in the cells [63]. Incubation of macrophages in the presence of acetyl-
LDL and an ACAT inhibitor led to a rise in cellular free cholesterol, and at the same time, 
cellular sphingomyelin content [67]. A whole-animal feeding experiment showed that a 
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high cholesterol diet increased concentrations of cholesterol in the liver, whole plasma, and 
VLDL, and the increases were accompanied by an elevation in VLDL-sphingomyelin level 
and a decrease in catabolism of sphingomyelin in the liver [68]. It is very suggestive that 
the cell tends to accommodate changes in cellular free cholesterol content by modulating 
the concentration of sphingomyelin [63,67]. Regulation of dietary cholesterol uptake by 
the content of sphingomyelin in the apical membrane of intestine cells was implicated in 
an experiment with the human intestinal cell line CaCo-2 [69]. Treatment of the cells with 
SMase resulted in a 50% reduction in absorption of cholesterol from bile salt micelles and 
active neutral SMase activity was detected in membranes prepared from the cells and from 
human pancreatic juice [69]. All together, it is possible to conclude that the amount of 
cellular sphingomyelin, mainly plasma membrane sphingomyelin, could affect the cell's 
ability to accommodate cellular free cholesterol, and a decrease in the level of 
sphingomyelin can stimulate cholesteryl ester synthesis and inhibit cholesterol biosynthesis. 
The effect of this sphingolipid on cholesterol esterification is very likely through an effect 
on cellular free cholesterol, thus affecting the substrate pool size of ACAT. 
The fact that cholesterol can activate ACAT has been reported by many investigators 
for a long time, but the mechanism of activation was not known. There have been 
suggestions that the sterol stimulated ACAT activity through mechanisms of both a direct 
effect on substrate supply and a non-substrate modulation [1], but direct experimental 
evidence had been lacking due to the extreme difficulty of purifying the protein. The 
cloning of the human macrophage ACAT cDNA by Chang et al [4] has allowed the use 
of molecular biology as well as traditional biochemical techniques in exploration of the 
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structure and regulation of ACAT and cholesterol esterification in cells, tissues, and whole 
animals, and possible mechanisms for sterol-mediated activation of ACAT have been 
examined at the transcriptional, translational, and post-translational levels. 
When rabbits (male New Zealand White) were fed a high-fat/high-cholesterol diet 
for 8 weeks, the concentration of esterified cholesterol in the liver increased 164 fold and 
the hepatic ACAT activity increased 17 fold [42]. Analysis of changes in mRNA level in 
the liver revealed a 2 fold elevation in ACAT mRNA mass. When the same kind of rabbits 
were fed with the same diet for 3 weeks, a 10 fold increase in liver cholesteryl ester content 
was observed with no significant changes in ACAT mRNA mass being detected [70]. In 
vitro experiments with primary hepatocytes showed a 6-10 fold increase in cellular 
cholesteryl ester level upon treatment of the cells with P-VLDL or mevalonolactone for 3 
days, but no significant changes were observed in ACAT mRNA level and cellular free 
cholesterol content [70]. Inhibition of ACAT resulted in a reduced cholesterol ester 
synthesis with no detectable change in ACAT mRNA level [70]. Similarly, no differences 
were observed in the amount of ACAT mRNA in HepG2 cells under conditions of either 
cholesterol loading or cholesterol depletion, even though the whole-cell and microsomal 
ACAT activities were elevated or inhibited under these same conditions [71]. The above 
results suggest that regulation of the en2yme activity at the gene transcriptional level is 
probably not the major mechanism the cell uses to control cholesteryl ester synthesis 
[42,70,71]. Activation of ACAT upon cholesterol loading is more likely modulated by 
post-transcriptional steps, possibly by a direct and immediate effect of substrate availability. 
The modest change in the ACAT mRNA mass observed in the long term feeding 
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experiment implies that transcriptional activation of the en2yme activity may just be an 
adjustment to the chronic effect of cholesterol feeding, requiring a certain threshold of 
cholesterol level in the cell to activate gene transcription [42,70], On the other hand, the 
atherogenic feeding of the rabbits generated a disease-like state in the liver, that resulted 
in the entering of macrophages into the liver. The increase in ACAT mRNA level may 
simply reflect the increase in the amount of total mRNAs [42,70]. 
A chimeric polypeptide, consisting of glutathione S-transferase fused with the first 
131 amino acids of the human ACAT, was used to raise specific polyclonal antibodies 
against ACAT in rabbits [37]. When human fibroblasts, HepG2 cells, or CHO cells were 
cultured in the presence of LDL or 25-hydroxycholesterol, a substantial amount of 
cholesterol esterification was observed. Western blot analysis of ACAT concentration 
under these treatments revealed no significant changes in the protein mass, indicating that 
activation of cholesterol ester synthesis by the sterol does not require an increase in the 
en2yme mass. The implication of the result is that the sterol-mediated activation of ACAT 
is probably not being controlled at the translational level [37]. 
Functional expression of high ACAT activity in insect Sf9 cells, which do not have 
intrinsic ACAT activity and have a very low endogenous cholesterol level, allowed a 
detailed catalytic analysis of ACAT in the presence of cholesterol [4,5]. After being 
solubilized and reconstituted into liposomes, ACAT activity was assayed with increasing 
concentrations of cholesterol, and the activity was plotted and shown to change as a 
function of cholesterol concentration in a sigmoidal pattern [5]. Using ^H-25-
hydroxycholesterol as the substrate, the formation of ^H-25-hydroxycholesteryl oleate was 
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shown to be activated by addition of cholesterol in a sigmoidal pattern [5]. Since only the 
protein-coding sequence of ACAT was used in the expression of the enzyme, any inhibitory 
factors of ACAT that may exist endogenously in the cell could not account for the 
activation [5]. The experiments demonstrate clearly that cholesterol serves not only as a 
substrate of the enzjnne, but interacts cooperatively with ACAT and acts as an allosteric 
activator [5]. Summarizing all the experiments on the gene transcription, translation, and 
post-translation studies, it is reasonable to conclude that, in mammalian cells, the primary 
mechanism of the sterol-mediated activation of ACAT lies at a post-translational step 
through a dual fimction of cholesterol, acting as both a substrate and an allosteric regulator 
of the enzyme. 
In mammalian systems, 25-hydroxycholesterol among other oxysterols has been 
found to form endogenously in animals and cultured cells, and can be esterified, or 
metabolized to bile salts and steroid hormones [72-74]. Not only is the existence of 25-
hydroxycholesterol physiologically relevant, it has been shown to affect cholesterol 
metabolism by affecting rate-limiting enzymes. 25-Hydroxycholesterol interacts with sterol 
regulatory element binding proteins, which are gene transcriptional activators of cholesterol 
biosynthesis and the LDL receptor, and suppresses endogenous synthesis of cholesterol and 
exogenous uptake from LDL [46]. It also stimulates cholesteryl ester formation in cells or 
microsomal preparations by activating ACAT in mammalian systems [5,46,72,74]. 
Experiments with cell cultures showed that addition of 25-hydroxycholesterol to cells did 
not cause changes in ACAT mRNA and protein mass even though it increased the enzyme 
activity [37,71]. In rat liver microsomes, 25-hydroxycholesterol activated ACAT and 
cholesterol esterification, and the activation seemed not to be mediated by an effect on the 
rate and extent of cholesterol transfer between liposomes and microsomes [72]. In both 
intact cells and cell extracts, the oxysterol was shown to activate ACAT, but the amplitude 
of activation diminished with the addition of increasing concentrations of cholesterol [5], 
It seemed that the effect on ACAT activation by the oxysterol is more on accessibility of 
cholesterol to the enzyme [5]. More studies are needed to clear the discrepancy and 
explore the mechanism of activation. Taken together, it is probable that 25-
hydroxycholesterol acts as a physiological regulator of cholesterol ester synthesis and it 
exerts its effect on post-translational steps. 
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CHAPTER in. MATERIALS AND METHODS 
A. Materials 
Chicken eggs, 16-days after fertilization, were obtained from Hy-Vac (Adel, Iowa). 
Mouse livers of female mice (Strain FVB) were kindly provided by Dr. Chris Tuggle's lab 
(Animal Science, Iowa State University). Protease inhibitors (aprotinin, pepstatin, 
leupeptin, antipain, benzamidine, and ALLN) were from Sigma Chemical Co. (St.Louis, 
MO). 2-MercaptoethanoI, DL-dithiothreitol, iodoacetamide, A/'-ethylmaleimide, p-
hydroxymercuri-benzoate sodium salt, MES, HEPES, 2,2'-dithiodipyridine, 5,5'-dithiobis(2-
nitrobenzoic acid), sodium dodecyl sulfate, cholic acid sodium salt, Triton X-lOO, 4-
aminoantipyrine, sodium 3,5-dichloro-2-hydroxybenzene sulfonate, methyl-P-cyclodextrin, 
cholesterol, 25-hydroxycholesterol, oleoyl coenzyme A, sphingomyelin, L-a-phosphatidyl-
L-serine, 1,2-dipalmitoyl-DL-a-phosphatidylethanolamine, dioleoyl-L-a-
phosphatidylcholine, L-a-lysophosphatidylcholine, triolein, dioleoylglycerol, cholesteryl 
oleate, oleic acid, linolenic acid, long chain ceramide (bovine brain), dihydrosphingosine, 
sphingomyelinase, horseradish peroxidase, and cholesterol oxidase were all from Sigma. 
Phosphatidylcholine, 20 mg/ml in chloroform, was isolated from chicken eggs following 
a procedure by White et al [75]. 5-Cholesten-3P,25-diol 3-oleate was purchased from 
Steraloids Inc. (Wilton, NH). 20(R)-20,25-Dihydroperoxy-cholest-5-ene-3p-ol was prepared 
as described by Tipton et al [76]. p-Methylaminophenol sulfate, 1,4-butanedithiol, diethyl 
pyrocarbonate, and A'^butylmaleimide were purchased from Aldrich Chemical Co. 
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(Milwaukee, WI). THAM, Na,"^ EDTA, sucrose, sodium bisulfite, sodium sulfite, 
perchloric acid, cupric sulfate, and 7 ml polyethylene scintillation vials, were obtained from 
Fisher Scientific (Fair Lawn, NJ). CHAPS and bovine serum albumin, fatty acid poor, 
were purchased from Calbiochem Co. (La Jolla, CA). Scintillation fluid, Ecolume, was 
obtained from ICN Pharmaceuticals Inc. (Costa Mesa, CA). l-'''C-01eoyl Co A was from 
DuPont NEN (Boston, MA). [la,2a(n)-^H]Cholesteryl oleate was from Amersham Life 
Science Inc. (Arlington, IL). Silica gel (40-140 mesh) was a product of J.T. Baker Inc. 
(Phillipsburg, NY). Plates for thin layer chromatography, silica gel 60 precoated, 20 X 20 
cm, were from Merck (Darmstadt, Germany). Pre-packed columns of Sephadex G-25 were 
from Pharmacia Biotech Inc. (Piscataway, NJ). Centricon 10 cartridges (molecular weight 
cutoff: 10,000) were from Amicon, Inc. (Beverly, MA). 
Sorvall RC-5B centrifuge (DuPont Instruments), L5-75 Ultracentrifuge (Beckman), 
Airfuge* Ultracentrifiage (Bechman), andUV160U spectrophotometer (Shimadzu) were used 
in the study. Packard Tri-carb 1600TR liquid scintillation analyzer with a dual radioisotope 
counting program was used for radioactivity counting. LiposoFast extrusion device from 
Avestin, Inc. (Ottawa, Canada) was employed for liposome preparation. 
B. Methods 
1. Preparation of volk sac membrane microsomes from fertilized chicken eggs The 
procedure described by J.H. Shand et al [6] was followed. Yolk sac membranes were 
isolated from 16- or 15-day old chick embryos, which were reported to have maximal 
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AC AT activity [6]. The membrane was washed in ice-cold NaCl (0.9%) 4 or 5 times to 
remove excess yolk. The following steps were performed at 4''C. After homogenation of 
the yolk sac membrane by a mechanical homogenizer in about 3 volumes of medium 1 
(0.25 M sucrose, 1 mM EDTA, 10 raM Tris-Cl, pH 7.4), the membrane homogenate was 
centrifiiged at 10,200 g for 15 min. Most of the time, the lipid associated with the 
membrane was so abundant that a yellow fat layer formed at the top of the homogenate. 
When this occurred, the imderlying solution was removed and centrifiiged a second time 
to remove the remaining fat. The reddish cloudy solution was then centrifiiged at 106,500 
g for 30 min. The pellet was suspended in medium II (50 mM MES, 50 mM Tris-Cl, pH 
7.2) and centrifiiged at 106,500 g for another 30 min. The new pellet was resuspended in 
medium II. The microsomes had protein concentrations of 20 to 50 pg/fil and were stored 
in aliquots at -70°C. In the study of the effect of protease inhibitors on ACAT activity 
upon storage, the microsomes were prepared in medium II plus 1 fig/ml each aprotinin-
pepstatin-leupeptin-antipaiii and 17 ng/ml benzamidine. 
When the effect of ALLN on ACAT activity during storage at 4°C was studied, 450 
[il microsomes or microsomes plus protease inhibitors were mixed with 50 fil 10 |ig/ml 
ALLN, dissolved in medium II, to make a final ALLN concentration of 1 |ag/ml. The 
mixture was stored at 4*'C for 10 days and assayed for ACAT activity on the day it was 
prepared and every other day thereafter. In a study of the effect of DTT on ACAT activity 
during storage at 4°C, a similar procedure was followed except the final DTT concentration 
was 1 mM. 
Protein concentration was determined by the Lowry method [77]. 
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2. Preparation of mouse liver microsomes Mice were sacrificed by cervical 
dislocation and livers were isolated on ice. The livers were homogenized in about 3 
volumes of medium I and centrifuged at 10,000 g at 4°C for 30 min. The supernatant was 
centrifuged at 106,255 at 4°C for one hour. The pellet was washed in medium II plus 
protease inhibitors (1 (ig/ml each aprotinin-pepstatin-leupeptin-antipain and 17 |ig/ml 
benzamidine) and centrifuged again. The new pellet was resuspended in medium II-
protease inhibitors and stored at -70°C in aliquot. 
3. Solubilization of microsomal ACAT Zwitterionic detergent CHAPS was used to 
extract ACAT firom microsomes. Typically, the solubilization mixture contained 0.5% 
CHAPS and 0.5 M NaCl in medium II, and the protein to CHAPS ratio was 1 to 1 (w/w). 
The mixture was shaken slowly at 4°C for 30 min and centrifuged at 106,500 g at 4''C for 
one hour. ACAT activity and protein content of the extract were determined for each 
preparation. To determine ACAT activity, one volume of the extract was preincubated at 
room temperature (r.t.) for 30 min with nine volumes of liposomes of 0.30 mole fraction 
of cholesterol in egg PC followed by the regular ACAT assay procedure. 
4. ACAT assav The assay for ACAT followed exclusively M. Shih's work [3]. 
One hundred and sixty microliters of microsomes with 15 to 250 (ig protein were 
preincubated at 37°C for 10 min. To start the esterification reaction, 40 fil of '''C-oleoyl 
CoA solution (250 ^xM '''C-oleoyl CoA-0.5 mg/40 |il BSA, 25 dpm/pmole) was added to 
the assay mixture. Afiter 5 min, 2 ml of hexane/2-propanol (3/2, v/v) was added to 
terminate the reaction. Ten |il of cholesteryl-^H-oleate (about 20,000 dpm) was introduced 
to the mixture as an internal standard. The organic layer was separated and dried under a 
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stream of Nj. The solid residue was redissolved in 200 p.1 hexane/diethyl ether (98/2, v/v) 
and applied onto a column of 0.7 g Silica gel (40-140 mesh) which had been prewashed 
with 3 ml hexane/diethyl ether. The cholesteryl oleate was eluted from the column with 
6 ml hexane/diethyl ether and collected in a 7 ml scintillation vial. After evaporation of 
the solvent, 200 (il of the same solvent was added to the vial followed by 5 ml Ecolumn 
counting fluid. The amount of cholesteryl-"''C-oleate formed was determined by dual 
radioisotope counting. 
25-Hydroxycholesterol can be esterified by ACAT under the assay condition 
[5,72,74], but the ester with oleate (5-cholesten-3p,25-diol 3-oIeate) does not elute out of 
the silica colimm with the elution solvent used in the assay, as demonstrated by the result 
of TLC developed in 90:10:1 (v/v/v) petroleum ether;dithyl ether:acetic acid. Thus, in the 
ACAT assay in the presence of 50 jiM 25-OH, the radioactivity eluted from the column 
was associated only with cholesteryl oleate. 
When exogenous cholesterol was needed, microsomes were incubated first with 
liposomes of cholesterol-phosphatidylcholine at room temperature for 30 min followed by 
the regular assay procedure. 
5. DTDP treatment of ACAT extract For this particular experiment, ACAT extract 
was prepared in 100 mM HEPES, pH 8.0, a proper condition for DTDP treatment. ACAT 
extract was incubated with 10 mM lAM-HEPES at r.t. for 20 min in the dark followed by 
different concentrations of DTDP/EtOH at 30°C for 75 min. The concentration of EtOH 
was 1% (v/v). To remove 2-thiopyridine and unreacted lAM and DTDP, a pre-packed 
column of Sephadex G-25 was used and 0.5% CHAPS-0.5 M NaCl-medium II was the 
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elution buffer. The eluant was concentrated using a Centricon 10 cartridge (molecular 
weight cutoff: 10,000). The amount of free thiol was determined by DTNB method [78] 
and 1% SDS was necessary to get clear solutions. 
6. Treatment of ACAT with chemical reagents An aliquot of 9.7 mg of PMB was 
mixed with 13.454 ml of medivmi II and stirred vigorously for a few hours. The 
suspension was allowed to stay undisturbed overnight. The clear supematant was 
transferred to another container, and the concentration of PMB was determined 
spectrophotometrically by using a molar extinction coefficient of 4400 M''cm ' [79]. The 
PMB solution was stored in the dark and at room temperature. The incubation of 
microsomal ACAT with PMB was 10 min at 37®C. 
Stock solutions of 1AM, NEM, NBM, and 2-Mer were prepared in medium II. Due 
to limited solubility in aqueous buffer, BdiT, DEPC, and HP-B were dissolved in EtOH. 
In that case, the final concentration of EtOH was 1% (v/v) and EtOH treated microsomes 
were used as the control microsomes. The concentration of HP-B was determined using 
Xylenol Orange method and HjO, as the standard [80]. Treatment of microsomes with 
1AM, NEM, and NBM was 20 min at r.t. in the dark and treatment with 2-Mer and BdiT 
was 30 min at 37°C. Treatment with DEPC was 10 min at 37°C. Proper controls were 
prepared under exact time and temperature conditions except buffer replaced the reagents. 
To measure the amount of thiol remaining after treatment of microsomes with thiol-
reactive agents, the microsomes were centrifuged at 100,000 g at 4°C for 30 min, and 
washed twice before being resuspended in medium II. The amount of thiol was determined 
by the DTNB method [78] with 1% SDS. 
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7. 0?ddative modification of microsomes Five fil of microsomes with 170 jig 
protein was diluted into 155 nl HjOj-medium II solutions of different concentrations. The 
mixture was incubated at r.t. for 60 min followed by the regular ACAT assay. The 
concentration of the original stock solution of HiO, was determined spectrophotometrically 
using a molar extinction coefficient of 43.6 M"' cm"' at 240 nm [81]. 
Forty |al of microsomes with 1360 |xg protein was diluted into 600 |il CUSO4-
medium II solution and the final CUSO4 concentration in the mixture was 5 ^M. The 
mixture was shaken at r.t. overnight. Eighty |al of CuS04-treated microsomes was mixed 
with 80 |il 2 mM EDTA-medium II and shaken at r.t. for 30 min followed by the regular 
ACAT assay. Two controls were made in this experiment. One control, labeled as 
overnight control, was prepared along with the CUSO4 treatment and used to assess the 
effect of 1 mM EDTA. The other control, labeled as zero-time control, was prepared by 
thawing an aliquot of microsomes and assayed for ACAT activity, along with the overnight 
control and CUSO4 treated microsomes. 
When the effect of minor membrane lipid molecules was studied, 5 |il of 
microsomes with 170 |xg protein was mixed with 153.4 |al medium II and 1.6 |al EtOH 
solutions of linolenic acid, or lysoPC, or DOG, or bovine brain ceramides, or DHS. The 
final EtOH concentration was 1% (v/v) and the final concentrations of linolenic, DOG, or 
DHS were 100 nM while those of lysoPC and ceramides were 0.0025% (w/v). The 
mixture was shaken at r.t. for 60 min prior to the regular ACAT assay. 
8. Quantitation of synthesis of cholestervl ester, triacvlelvcerol and phospholipids 
Five |al of microsomes with 220 |ag protein was incubated with 155 |^1 medium II or 
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MpCD-medium II at r.t. for 30 min. The concentration of MpCD in the treatment was 1 
mM. The mixture was incubated at 37°C for 10 min prior to the addition of 40 |il ''*C-
oleoyl CoA. Two ml 2/1 (v/v) chloroform/MeOH was added to the mixture after a 5 min 
reaction time at 37*'C followed by the addition of 10 |il ^H-cholesteryl oleate. The top 
aqueous layer was extracted one more time with 2/1 chloroform/MeOH and the organic 
extracts were combined and dried under N,. The solid residue was redissolved in 50 |il 2/1 
(v/v) chloroform/MeOH and applied onto a TLC plate which had been pre-washed in 
MeOH for 5 min and air-dried completely. For the quantitation of neutral lipids, the plate 
was developed in petroleum ether:diethyl etherracetic acid, 80:20:0.5 (v/v/v) [82] and for 
complex lipids in chloroform:methanol:water:acetic acid, 70:30:4:2 (v/v/v/v) [83]. 
Compared with standards, the spots corresponding to CE, TAG or PL were scraped into a 
scintillation vial and counted for radioactivity. 
9. Cholesterol depletion experiment One ml of microsomes was mixed with 5 ml 
methyl-P-cyclodextrin solution and stirred slowly at 4°C for one hour. The amount of 
protein in the microsomes was 44 mg. The mixture was centrifiiged at 106,500 g at 4''C 
for 30 min. The pellet was suspended in 1.3 ml medium II and subjected to the same 
treatment with methyl-P-cyclodextrin (MpCD) two more times. One wash with medium 
II after the third depletion was needed to get rid of MpCD. Gentle homogenization was 
sometimes needed during resuspension and the final microsomes were prepared in a small 
volume of medium II to have a concentrated protein solution. The amount of ACAT 
activity, protein content, cholesterol and phospholipid concentration were measured after 
each step of depletion. 
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10. Preparation of liposomes The liposomes were prepared following the procedure 
of R.C. MacDonald et al [84]. Cholesterol was recrystallized twice from methanol and 
dissolved in chloroform. A solution of phosphatidylcholine, 20 mg/ml in chloroform, was 
mixed with different amounts of cholesterol/chloroform so that certain mole ratios of 
cholesterol to PC were obtained. The combined solution was dried first under a stream of 
N, and then under vacuum at 40-45"C for 30 min. The waxy residue was suspended in 
medium II and the final PC concentration was 10 mg/ml. The mixture was then frozen and 
thawed 10 times, using a dry ice-ethanol bath and r.t. water bath, respectively. The 
multilamellar vesicles were extruded 19 times through 2 polycarbonate membranes (100 nm 
pore size) mounted on an extrusion device. The imilamellar liposomes were stored under 
N, at 4°C. The concentrations of cholesterol and PC were determined for each liposome 
preparation. 
11. Determination of cholesterol concentration The procedure described by Omodeo 
Sale et al [85] was followed with moderate modification. Cholesterol was extracted three 
times from microsomes or liposomes using 3/2 (v/v) hexane/2-propanol. The solvent was 
evaporated under Nj, and the solid residue was redissolved in ethanol. Reagent A 
contained 822 |aM 4-aminoantipyrine, 1.9mMNa3,5-dichloro-2-hydroxybenzene sulfonate, 
200 lU/L peroxidase and 50 mM phosphate buffer (3 mM Na cholate-0.5% Triton X-100, 
pH 7.0) and was prepared on the day of the assay. To a 200 |al sample or standard 
containing 5 to 20 pig cholesterol in ethanol, 1 ml reagent A was added. After a 10 min 
incubation at 37°C, absorbance at 505 nm was measured and taken as blank. Ten [il 25 
lU/ml cholesterol oxidase dissolved in 50 mM phosphate buffer was added to the sample 
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prior to a second incubation at 37°C for 15 min. The absorbance at 505 nm was measured 
again, and the difference between the two readings was used to calculate the amount of 
cholesterol. 
12. Determination of phospholipid concentration Phospholipid concentration was 
determined according to W.D.Harris et al's work [86], and the assumption was made that 
the majority of phospholipid in the microsomes or liposomes had one mole of phosphorus 
per mole of phospholipid. An aliquot of microsomes or liposomes in a final volume of 120 
|al was mixed with 1 ml 70% perchloric acid. For the supernatant in the cholesterol 
depletion experiment, a larger volume of sample, e.g. 500 ^il, was used to ensure a large 
enough sample of phosphorus and the sample was fu^st evaporated to dryness and then 
redissolved in 120 |il water. After digestion, 200 |al of digest was diluted with 1.7 ml HiO 
followed by 200 |al 5% ammoniiun molybdate and 400 |al Elon reducing reagent. 
Absorbance at 795 rmi was measured 10 min later. 
13. Thin-laver chromatography of volk sac membrane microsomes and cholesterol 
depletion supernatant Lipids in microsomes or the cholesterol depletion supernatant were 
extracted by 2/1 (v/v) chloroform/methanol. After evaporation of the extraction solvent, 
the solid residue was redissolved in 2/1 chloroform/MeOH to make a solution of 20 mg/ml. 
All the lipid standards were dissolved in chloroform, hexane, or ethanol depending on their 
solubility in different solvent systems. The TLC plate was washed in methanol for 5 min 
and air-dried completely. After application of sample and standards, the plate was 
developed twice, up to the middle of the plate, in 120:60:10 (v/v/v) 
chloroform:methanol:water, and the third time, all the way to the top of the plate, in 
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80:20:1.5 (v/v/v) hexane:diethyl ether:acetic acid according to a procedure in Lipid Analysis 
[87]. The spots were visualized by I, vapor. 
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CHAPTER IV. RESULTS AND DISCUSSION 
A. Results 
1. Comparison of ACAT of avian and mammalian sources 
Studies of structure and function of ACAT from different sources, mainly 
mammalian tissues, have been done using chemical reagents. In this work, a few thiol-
reactive agents and DEPC, a histidine-reactive chemical, were used to study ACAT from 
avian yolk sac membrane. 
As shown in Figure 1, 500 |iM DEPC inhibited ACAT activity 90%: 396 ± 10.6 
(zero DEPC) vs 41 ± 0.8 (500 |aM DEPC) pmole/min/mg. Higher concentrations of DEPC, 
e.g. 2 mM, did not result in a further decrease in the enzyme activity and the addition of 
1% (v/v) EtOH to microsomes had little effect: 360 ± 1.1 (microsomes) vs 396 ± 10.6 
(microsomes + EtOH) pmole/min/mg. 
Figure 2 shows the result of treating microsomes with PMB of different 
concentrations. The insert is a plot of ACAT SA against PMB concentration from zero to 
20 jiM. ACAT activity increased when the concentration of PMB increased from zero to 
20 |j.M: 437 ± 3.8 (zero PMB) (100%) vs 526 ± 16.2 (20 |iM) (120%) pmole/min/mg, and 
then dropped dramatically: 437 ± 3.8 (zero |aM) (100%) vs 7.8 ± 0.4 (100 |iM) (2%) 
pmole/min/mg. 
Treatments of microsomes with I AM, or NEM, or NBM were repeated several times 
during the course of the study. The result of one of those experiments is plotted in Figure 
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Figure 1. Effect of DEPC on ACAT activity. Five (li of microsomes was incubated 
at 37°C for 10 min with 155 ^il medixun n containing different 
concentrations of DEPC. The stock solution of DEPC was prepared in 
EtOH and EtOH treated microsomes were the control. The final 
concentration of EtOH was 1% v/v. Each value is a mean of duplicates with 
a bar showing the range; where no bar is shown, it is smaller than the 
symbol. 
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Figure 2. Effect of PMB on ACAT activity. Five ^.1 of microsomes was incubated at 
37°C for 10 min with 155 |il medium II containing different concentrations 
of PMB. The insert was a plot of ACAT SA against PMB concentration 
&om 0 to 20 |iM. Each value is a mean of duplicates with a bar showing 
the range; where no bar is shown, it is smaller than the symbol. 
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3. Incubation of microsomes with I AM resulted in an increase in AC AT activity: 135 ± 
3.2 (zero lAM) (100%), 168 ± 1.0 (1 mM lAM) (124%), and 204 ± 2.8 (20 mM lAM) 
(151%) pmole/min/mg (Figvire 3, lAM treatment). An increase in ACAT activity was 
consistently observed with 20 mM lAM incubation, even though the magnitude changed 
a little each time, ranging from 113% to 152% of the control. Treatment of microsomes 
with 1 mM NEM increased the enzyme activity to a small extent: 120 ± 1.0 (zero NEM) 
(100%) vs 139 ± 2.0 (1 mM NEM) (116%) pmole/min/mg. Treatment of microsomes with 
20 mM NEM produced more variable results, 78% of the original ACAT activity remained 
in the experiment shown in Figure 3 (NEM treatment), while 101% and 113% of the 
original activity were obtained in another two experiments (data shown in Figure 4). 
Incubation of microsomes with a more hydrophobic maleimide derivative, NBM, resulted 
in an increase in the enzyme activity first: 426 ± 4.1 (zero NBM) (100%) vs 518 ± 10.7 
(1 mM NBM) (122%) pmole/min/mg, and then a dramatic decrease: 426 ±4.1 (zero NBM) 
(100%) vs 4.9 ± 0.4 (20 mM NBM) (1%) pmole/min/mg (NBM treatment). The same 
result, 1% of the original activity in the treatment with 20 mM NBM, was obtained in 
another experiment (see Figure 4). The difference in ACAT activity in control microsomes 
in the experiments shown in Figure 3 was because of the use of different batches of 
microsome preparations. 
Microsomes were treated sequentially with 20 mM lAM or NEM followed by 500 
|iM PMB or 20 mM NBM, shown in Figure 4 (A or B). Treatment of microsomes with 
500 |iM PMB resulted in a 98% inhibition of the enzyme activity (Figure 4A): 7.8 ± 0.1 
(500 ^M PMB, bar b) vs 484 ±3.4 (control, bar a) pmole/min/mg. Treatment of 
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Figure 3. Effect of thiol-reactive agents on ACAT activity. Five of microsomes 
was incubated at r.t. for 20 min in the dark with 155 |al medium II 
containing LAM, or NEM, or NBM followed by the regular en2yme assay. 
Each value is a mean of duplicates with the range indicated by error bars. 
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Figiire 4. Effect of sequential treatment of microsomes with thiol-reactive agents on 
ACAT activity. In Figure A, 5 pi of microsomes was mixed with 40 |il 
mediimi II containing lAM or NEM and incubated at r.t. for 20 min in the 
dark. An aliquot of 115 |xl PMB solution was added to the mixture prior to 
the second incubation at 37°C for 10 min. Bar a represents the control, bar 
b represents the treatment with 500 jiM PMB, bar c represents the treatment 
with 20 mM lAM, bar d represents the treatment with 20 mM NEM, bar e 
represents the treatment with 20 mM lAM + 500 (iM PMB, and bar f 
represents the treatment with 20 NEM + 500 pM PMB. In Figure B, similar 
treatment of microsomes with 20 mM NEM and 20 mM NBM was 
performed except the condition for treatment with NBM was at r.t. for 20 
min in the dark. Each value is a mean of duplicates and in all the cases, the 
error range was < 12% of the mean. 
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microsomes with 20 mM lAM or NEM resulted in an increase of 32% or 13% of the 
control activity: 639 ±3.2 (20 mM lAM, bar c) or 549 ± 9.4 (20 mM NEM, bar d) 
pmole/min/mg. Pretreatments of microsomes with 20 mM lAM or NEM did not protect 
the enzyme from the inactivation caused by incubation with 500 |iM PMB. There was 5% 
enzyme activity remaining after lAM + PMB treatment: 23 ± 1.0 (bar e) pmole/min/mg , 
and 1% remaining after NEM + PMB treatment: 4.7 ± 0.1 (bar f) pmole/min/mg. A similar 
experiment, shown in Figure 4B, was performed with a pretreatment of microsomes with 
20 mM NEM followed by 20 mM NBM, at r.t. for 20 min in the dark. Incubation of 
microsomes with 20 mM NEM had no effect on ACAT activity: 499 ± 6.3 (20 mM NEM) 
vs 493 ± 13.3 (control) pmole/min/mg. Treatment of microsomes with 20 mM NBM 
caused a complete inactivation of the enzyme: 4.9 ±0.1 (20 mM NBM) pmole/min/mg, and 
preincubation with 20 mM NEM did not prevent the inactivation: 4.7 ± 0.6 (20 mM NEM 
+ 20 mM NBM) pmole/min/mg. 
The thiol content in microsomes with or without the treatment of thiol-reactive 
agents was measured (column 2 in Table 1) and the percentage of reagent-reactive SH was 
calculated (column 3 in Table 1). PMB at 20 |iM modified 6% of the total microsomal 
thiols and caused a 20% increase in ACAT activity. PMB at 100 ^iM modified 29% of the 
thiols and inactivated the enzyme completely (2% of the control activity). Treatment of 
microsomes with 20 mM lAM modified 18% of the total thiols and increased ACAT 
activity from 13% to 52% (varied from experiment to experiment). NEM at 20 mM 
reacted with 45% and 44% of total microsomal thiols and had an effect on activity that was 
more variable: from 78% to 113% of the control. Treatment of microsomes with 20 mM 
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Table 1. Thiol content in microsomes. Forty ^l of microsomes with 1520 jag protein 
was incubated with 160 jxl thiol-reactive agents. Microsomes were 
centrifuged at 100,000 g at 4°C for 30 min and washed twice. The thiol 
content is expressed as nmol per mg protein. 
SH remaining after Percent of SH reacted 
modification with the reagent 
microsomes® 57.4 ± 0.6 — 
20 nM PMB 54.2 ±0.1 6 
100 PMB 40.8 ±1.0 29 
20 mM lAM 47.3 ±0.2 18 
microsomes'* 61.4 ± 0.5 — 
20 mM NEM 34.0 ±1.3 45 
20 mM NBM 23.5 ± 0.5 62 
microsomes'^ 58.2 ± 0 — 
20mMNEM 32.4 ±0.1 44 
20 mM NBM 22.8 ± 0.7 61 
\ are different experiments with the same batch of microsomal preparation. 
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NBM inhibited AC AT completely (1% of the control) and the thiols that were modified 
were 62% and 61%. 
Solubilization of AC AT was achieved by using the zwitterionic detergent CHAPS. 
The ACAT SA in microsomes and extracts and resuspended pellets of different CHAPS 
concentrations is shown in Figxire 5. The CHAPS to protein ratio in 0.5%, 1%, 1.5%, 
2% CHAPS solubilization mixtures was 1:1, 2:1, 3:1, 4:1 by weight, respectively. 
Solubilization of ACAT using 0.5% CHAPS with a detergent to protein ratio of 1:1 by 
weight gave the highest activity in the extract, and 0.5% CHAPS was used in the following 
solubilization experiments. 
Microsomes were solubilized with 0.5% CHAPS-medium II or 0.5% CHAPS + 0.5 
M NaCI-medium 11 and the pellet was resuspended in 0.5% CHAPS-medium II, shown in 
Figure 6A. The addition of 0.5 M NaCl to the solubilization mixture caused an increase 
in ACAT activity in the extract and in the ratio to that in the pellet: without NaCl, ACAT 
SA was 109 ± 0.4 pmole/min/mg in the extract and 311 ±4.2 pmole/min/mg in the pellet 
(panel a), with NaCl, ACAT SA was 1671 ± 41.3 and 251 ± 3.8 pmole/min/mg, 
respectively (panel b). In Figure 6B, microsomes were solubilized with 0.5% CHAPS + 
0.5 M NaCl-medium II and the pellet was resuspended in either 0.5% CHAPS-medium II 
(panel c) or 0.5% CHAPS + 0.5 M NaCl-medium II (panel d). The presence of 0.5 M 
NaCl in resuspension buffer increased the enzyme activity m the resuspended pellet. 
Results of Figure 22A and B were from two different batches of microsomal preparation. 
When microsomes were solubilized with 0.5% CHAPS-0.5 M NaCl-100 mM 
HEPES, pH 8.0, the extract was treated with 10 mM lAM followed by different 
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PeUet 
Figure 5. Solubilization of ACAT of yolk sac membrane by CHAPS. Eight-four ^l 
of microsomes with 3 mg protein was mixed with 516 ^1 medium II of 
different concentrations of CHAPS. After centrifugation, the pellet was 
resuspended in medium H with various CHAPS concentrations. Each value 
is a mean of duplicates with the range indicated by error bars. 
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Figure 6. Solubilization of ACAT of yolk sac membrane by CHAPS. In Figure 6A, 
microsomes were solubilized with 0.5% CHAPS-medium 11, panel a, or 0.5% 
CHAPS + 0.5 M NaCl-medium 11, panel b, and the pellet was resuspended 
in 0.5% CHAPS-medium II. In Figure 6B, microsomes were solubilized 
with 0.5% CHAPS + 0.5 M NaCl-medium II and the pellet was resuspended 
in either 0.5% CHAPS-medium 11, panel c, or 0.5% CHAPS + 0.5 M NaCl-
medium II, panel d. Each value is a mean of duplicates with the range 
indicated by error bars. 
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concentrations of DTDP, shown in Figure 7. As the thiol content in the extract decreased, 
in the presence of increasing concentration of DTDP, ACAT SA decreased. At 2 mM 
DTDP, the thiol content in the extract was 80% of the original: 20.0 ± 0.05 (2 mM DTDP) 
vs 25.0 ± 0.05 (zero DTDP) nmole/mg protein and the enzyme activity was 22% of the 
original: 106 ± 0.5 (2 mM DTDP) vs 493 ± 28.6 (zero DTDP) pmole/min/mg. 
To compare reactivity of mouse liver microsomal ACAT towards thiol-reactive 
agents with the yolk sac enzyme, mouse liver microsomes were prepared and treated with 
20 mM I AM or NEM, or NBM, 10 ^iM, 1 mM, and 20 mM, shown in Figure 8. Treatment 
of mouse liver microsomes with 20 mM lAM caused a little reduction in ACAT activity: 
754 ± 1.0 (control) (100%) vs 687 ± 14.0 (lAM) (91%) pmole/min/mg, and treatment with 
20 mM NEM caused a substantial inactivation: 754 ± 1.0 (control) (100%) vs 164 ± 3.0 
(NEM) (22%) pmole/min/mg. NBM at 10 ^M had no effect on ACAT activity, and 1 mM 
and 20 mM NBM inhibited the enzyme 47% and 99% (402 ± 0.6 and 6 ± 0.1 
pmole/min/mg), respectively. 
Microsomes of yolk sac membrane or mouse liver were treated with 500 (iM PMB 
at 37°C for 10 min followed by either 5 mM 2-Mer, Figure 9A, or BdiT, Figure 9B, at 
37''C for 30 min. In the experiment shown in Figure 9A, PMB of 500 |iM completely 
inactivated ACAT of either yolk sac membrane or mouse liver: 2% or 1% of the 
corresponding controls. Reagent 2-Mer of 5 mM had no or little effect on ACAT of either 
source: 103% or 94% of the controls. For ACAT of yolk sac membrane, 5 mM 2-Mer 
recovered from the PMB treatment 87% of the original activity, while for the enzyme of 
mouse liver, 2-Mer had little effect on recovery: only 6% of the original was detected after 
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Figure 7. Effect of DTDP on ACAT activity and thiol content in the extract. An 
aliquot of 980 |il extract with 2352 jil protein was treated with 10 mM I AM 
followed by different concentrations of DTDP. Stock solution of DTDP was 
prepared in EtOH and EtOH treated extract was the control. The ACAT SA, 
represented by the line with circles, is scaled on the 1st Y axis and the thiol 
content, represented by the line with triangles, is scaled on the 2nd Y axis. 
Each value is a mean of duplicates with a bar showing the range; where no 
bar is shown, it is smaller than the symbol. 
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Figure 8. Effect of thiol-reactive agents on ACAT of mouse liver microsomes. Five 
|il of microsomes was incubated at r.t. for 20 min in the dark with 155 |j.l 
medium n containing lAM, or NEM, or NBM followed by the regular 
enzyme assay. The bar with - represents the value of microsomes, the 
crossed bar represents the value of 10 ^M NBM treated microsomes, the 
hatched bar represents the value of 1 mM NBM treated microsomes, and the 
filled bars represent the values of 20 mM reagent treated microsomes. Each 
value is a mean of duplicates. In all cases, the range is < 2% of the mean. 
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Figure 9. Effect of thiol-reactive agents on ACAT of yolk sac membrane or mouse 
liver. Microsomes were incubated with 500 {iM PMB at 37°C for 10 min 
followed by 5 mM 2-Mer, Figure 9A, or BdiT, Figure 9B, at 37°C for 30 
min. Each value is a mean of duplicates with the range indicated by error 
bars. 
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the sequential incubation. In Figure 9B, PMB at 500 |j.M inhibited the en2yme 53% or 
66% of the controls and 5 mM BdiT inhibited 36% or 68%. Sequential incubation of 
microsomes with PMB and BdiT activated ACAT of yolk sac membrane: 608 ± 0.5 
(control) (100%) vs 860 ± 28.6 (PMB + BdiT) (141%) pmole/min/mg, and the same 
treatment recovered 69% of the original activity in mouse liver: 850 ± 18.0 (control) vs 585 
± 90.5 (PMB + BdiT) pmole/min/mg. Experiments shown in Figure 9A and B used 
different batches of microsomes of either source and different stock solutions of PMB. 
Microsomes of yolk sac membrane or mouse liver were treated sequentially with 
cholesterol hydroperoxide (HP-B) and DTT, Table 2. The data of mouse liver are from Dr. 
M. Shih's dissertation [3]. ACAT of the avian source lost 22% of the control activity by 
oxidation of HP-B and DTT could recover completely the lost activity. On the other hand, 
HP-B was much more effective on inactivation of the mammalian enzyme and DTT could 
not reverse the inhibitory effect by HP-B oxidation. 
2. Effect of cholesterol redistribution on ACAT activity 
ACAT of yolk sac membrane was found to be quite tolerant of repeated freezing and 
thawing: SA of 753 ± 4.4 pmole/min/mg after the 1st cycle vs 842 ± 16.0 after the 6th 
cycle, an increase of 12%. Freezing and thawing is known to be destructive of protein 
structure and enzymes tend to become inactive after repeated freezing and thawing. To 
ftirther investigate this phenomenon, microsomes were thawed and stored at 4°C for 10 
days. The ACAT activity was measured on the day the membrane preparation was thawed 
(day 0) and every other day thereafter. The experiment was carried out 3 times; the 1st 
experiment started the next day after the microsomes were prepared, the 2nd experiment 
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Table 2. Effect of cholesterol hydroperoxides on AC AT activity. Microsomes were 
incubated with HP-B at 37°C for 15 min before being treated with DTT at 
37°C for 30 min followed by the regular AC AT assay. HP-B was prepared 
in EtOH solution and 1% (v/v) EtOH was the Control. 
ACAT SA Percent of 
pmole/min/mg control 
Yolk sac membrane microsomes: 
Control 231 ± 14.2 100 
1.2 mM DTT 245 ± 17.9 106 
138 ^iM HP-B 180 ± 30.6 78 
138 \iM HP-B + 1.2 mM DTT 226 ± 6.8 98 
Mouse liver microsomes": 
Control — — 
1.3 mM DTT 1203 100 
100 ^iM HP-B 112 9 
100 ^iM HP-B + 1.3 mM DTT 171 14 
" Data are from M. Shih's Ph. D. dissertation [3]. 
51 
was after 3.5 weeks storage at -70°C, and the 3rd after 7 weeks storage at -70°C. The 
results of these 3 experiments are plotted in Figure 10 as ACAT SA vs days of storage at 
4°C. 
As one could see from Figure 10, storage of microsomes at -70°C slowly inactivated 
ACAT. When the microsomes were just made and stored at -70''C overnight, the ACAT 
SA was 504 ± 6.4 pmole/min/mg (100%) (value at day 0). After 3.5 weeks storage at -
70°C, the SA decreased to 466 ± 7.9 pmole/min/mg (92%). After 7 weeks at -70°C, the 
SA decreased to 395 ±11.2 pmole/min/mg (78%). During storage at 4°C, the activity first 
increased, then slowly declined. 
To study the possible effects of proteases during storage and thawing, the same time 
course experiment as in Figure 10, was carried out, but with a mixture of protease 
inhibitors (1 (ig/ml each aprotinin-pepstatin-leupeptin-antipain and 17 |ag/ml benzamidine) 
included in the microsome preparation. Figure 11 shows the ACAT SA vs days of storage 
at 4°C in the absence (no inh) or presence (inh) of protease inhibitors. Figure 11A shows 
the result of the experiment conducted the day after the microsomes were prepared and 
stored at -70°C, while Figure IIB and IIC shows the results of experiments done 3.5 
weeks and 7 weeks later, respectively. 
As shown in Figure 11, the inclusion of protease inhibitors in microsome preparation 
results in a more sustained ACAT activity, compared to that in the absence of inhibitors. 
Even at the end of 10 days, the microsomes still had quite active ACAT: 673 ±1.9 (inh) 
vs 104 ± 0.9 (no inh) pmole/min/mg (Figure 11 A). However, it seems that any proteases 
that were present may have been inactivated during the storage at -70°C, and the effect of 
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Figure 10. Effect of storage at 4°C on ACAT activity. The microsomes were taken out 
of -70°C freezer and thawed and stored at 4°C. ACAT activity was 
measured on the day they were thawed (day 0) and every other day 
thereafter. The line with • represents the experiment carried out the next 
day after the microsomes were prepared, and the lines with a and • 
represent experiments done 3.5 weeks and 7 weeks later, respectively. Each 
vdue is a mean of duplicates with a bar showing the range; where no bar is 
shown, it is smaller than the symbol. 
Figiire 11. Effect of storage at 4°C on AC AT activity in the absence or presence of 
protease inhibitors. The microsomes with or without protease inhibitors 
were taken out of -70°C freezer and thawed and stored at 4°C. ACAT 
activity was measured the day after the microsomes were thawed and every 
other day thereafter. Data of Figure llA were collected the day after the 
microsomes were prepared, while those of Figure IIB and IIC were 
collected 3.5 weeks and 7 weeks later, respectively. Each value is a mean 
of duplicates with a bar showing the range; where no bar is shown, it is 
smaller than the symbol. 
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protease inhibitors on ACAT SA diminished dramatically. By the 7th week (Figure 1IC), 
ACAT was almost as active in the absence of inhibitors as in the presence of inhibitors. 
One of the interesting features observed in Figure 10 is that the ACAT SA goes up 
the first 2 days at 4°C prior to a decrease. In the 1st experiment, the enzyme specific 
activity on day 2 was 135% of that on day 0, while in the 2nd experiment, it was 173%. 
The biggest increase, to 179%, was seen in the 3rd experiment. To test the possible 
fxmction of cysteine proteases during 4°C storage period, a time course experiment similar 
to that shown in Figure 11 was carried out with the addition to microsomes of ALLN, a 
neutral cysteine protease inhibitor. The result of this experiment is shown in Figure 12. 
The addition of ALLN to microsomes had little effect on ACAT activity during storage at 
4°C, in the absence or presence of the mixture of protease inhibitors. 
The same time course experiment as shown in Figure 11 was repeated, with the 
addition of DTT to the microsomes on the day they were thawed. As shown in Figure 13, 
DTT had only a small effect on ACAT stability during storage at 4°C. 
Microsomes were treated with 5 |iM CUSO4 or HiO, of different concentrations to 
see whether oxidation of lipids had any effect on ACAT. Figure 14A shows the result of 
treating microsomes at r.t. for 60 min with increasing concentration of HjO,, and it was 
clear that even 1 mM HjO, had no effect on ACAT SA, 512 ± 11.4 (1 mM HjO,) vs 499 
±1.8 (control) pmole/min/mg. Figvire 14B shows the result of treating microsomes with 
5 i^M CUSO4 at r.t. overnight. To avoid any interference of CUSO4 with the ACAT assay, 
1 mM EDTA was added to the CUSO4 treated microsomes 30 min before the assay. As 
shown in Figure 14B, overnight incubation of the control microsomes resulted in an 
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Figure 12. Effect of ALLN on ACAT activity during storage at 4°C. Microsomes or 
microsomes + protease inhibitors were taken out of the -70°C freezer and 
thawed. An aliquot of 450 |al microsomes was mixed with 50 |il 10 |J.g/ml 
ALLN and stored at 4°C for 10 days. ACAT activity was measured the day 
the mixture was prepared and every other day thereafter. The lines with the 
solid symbols were the results of experiments without ALLN while the lines 
with open symbols were results with ALLN. Each value is a mean of 
duplicates with a bar showing the range; where no bar is shown, it is smaller 
than the symbol. 
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Figure 13. Effect of DTT on ACAT activity during storage at 4°C. Microsomes or 
microsomes + protease inhibitors were taken oxit of the -70°C j&eezer and 
thawed. An aliquot of 450 ^il microsomes was mixed with 50 ^il 10 |i.g/ml 
DTT and stored at 4°C for 10 days. ACAT activity was measured the day 
the mixture was prepared and every other day thereafter. The lines with the 
solid symbols were the results of experiments without DTT while the lines 
with open symbols were the results with DTT. Each value is a mean of 
duplicates with a bar showing the range; where no bar is shown, it is smaller 
than the symbol. 
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Figure 14. Effect of oxidation of microsomes on ACAT activity. Figure 14A shows the 
treatment of microsomes with H2O2 at r.t. for 60 min and Figure 14B shows 
the treatment of microsomes with 5 |iM CUSO4 at r.t. overnight. In Figure 
14B, bar a represents the zero-time control, bar b represents the overnight-
control, bar c represents the overnight-control with 1 mM EDTA added 30 
min before the assay, bar d represents the CUSO4 treatment with 1 mM 
EDTA added 30 min before the assay. The bar represents ACAT SA and 
is a mean of duplicates. The error range is represented by a bar; where no 
error bar is shown, it is too small to be shown. 
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increase in ACAT SA, 675 ± 14.6 (overnight, bar b) vs 447 ± 0.4 (zero-time, bar a) 
pmole/min/mg, while 5 pM CUSO4 treatment led to a decrease in the enzyme activity, 526 
± 1.6 (CUSO4 treated, bar d) vs 617 ± 27.5 (overnight + EDTA, bar c) pmole/min/mg. 
To test the possibility that the activity of ACAT was influenced by the formation 
of minor lipid molecules during 4°C storage period, microsomes were incubated at r.t. for 
60 min with 100 nM linolenic acid, 0.0025% (w/v) lysoPC, or 100 nM 1,2-dioleoylglycerol, 
or 0.0025% (w/v) bovine brain ceramides, or 100 nM dihydrosphingosine. The stock 
solutions of those lipid molecules were prepared in EtOH and the final concentration of 
EtOH in these treatments was 1% (v/v). The result of this experiment is shown in Table 
3. The addition of 1% (v/v) EtOH to microsomes had negligible effect on ACAT activity. 
The addition to microsomes of 100 nM linolenic acid, or 100 nM DOG, or 0.0025% (w/v) 
ceramides, or 100 nM DHS had little or no effect on ACAT activity. The decrease in 
ACAT SA seen in the treatment with 0.0025% (w/v) lysoPC could be due to the 
reacylaticn of lysoPC, competing for acyl-CoA used for the ACAT assay. 
Microsomes were incubated with MpCD and the formation of cholesteryl ester, 
triacylglycerol, and phospholipids in the microsomes was measured. First, to find out if 
MpCD had an effect on ACAT activity, and the optimal concentration of the cyclodextrin, 
microsomes were treated with MpCD at r.t. for 30 min followed by the regular ACAT 
assay. As shown in Figure 15, incubation of microsomes with MpCD stimulated the 
enzyme activity with an optimal concentration between 1 and 5 mM; ACAT SA: 1088 ± 
33.7 (1 mM) vs 278 ± 4.6 (0 mM) pmole/min/mg, a 3.9 fold increase. Then, the synthesis 
of CE, TAG, and PL in the presence of 1 mM MpCD was measured, and the result is 
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Table 3. Effect of minor membrane lipids on AC AT activity. Microsomes were 
incubated with lipids at r.t. for 60 min with shaking followed by the regular 
ACAT assay. EtOH was used to prepare stock solutions of the lipids and 
the final concentration of EtOH in these treatments was 1% (v/v). 
Treament 
ACAT SA 
pmole/min/mg 
Percent of 
control 
Microsomes 552 ± 3.2 — 
1% (v/v) EtOH 564 ± 1.5 100 
100 nM linolenic acid 563 ± 11.1 100 
0.0025% (w/v) lysoPC 368 ± 4.9 65 
100 nM DOG 566 ± 6.8 100 
Microsomes 507 ± 2.9 — 
1% (v/v) EtOH 527 ± 17.2 100 
0.0025% (w/v) ceramides 595 ± 11.8 113 
100 nM DHS 556 ± 8.0 106 
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Figiire 15. Effect of MpCD on ACAT activity. Five ^il of microsomes with 220 
protein was incubated with 155 |il MpCD-medium II at r.t. for 30 min 
followed by the regular ACAT assay. Each value is a mean of duplicates 
with a bar showing the range; where no bar is shown, it is smaller than the 
symbol. 
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plotted in Figure 16. The synthesis of CE was elevated 3.8 fold in the presence of MpCD: 
1782 ± 5.4 vs 471 ± 24 pmole/min/mg, whereas those of TAG and PL did not change 
significantly: TAG: 64.7 ± 2.2 (1 mM MpCD, 70%) vs 92.6 ± 12 (control, 100%) 
dprn/min/jig, PL: 76.2 ± 1.2 (1 mM MpCD, 132%) vs 57.5 ± 9.6 (control, 100%) 
dpm/min/^g. 
3. Regulation of ACAT activity by (oxy)sterols 
In an attempt to investigate the flmction of cholesterol and 25-hydroxycholesterol 
in regulation of ACAT of yolk sac membrane, an experiment was conducted in which 
cholesterol of microsomes was depleted by incubation of microsomes with MpCD and the 
depleted microsomes were assayed for ACAT activity after being incubated with 
cholesterol-PC liposomes of different molar ratios. The experiment was carried out as 
follows. 
First, microsomes were treated with 10 mM MpCD 3 times and the amount of 
cholesterol was measured after each step of depletion. As shown in Figure 17 (1st panel 
of bars), there was 41% of the original cholesterol left after the 1st depletion, and 22% and 
23% left after 2nd and 3rd depletions, respectively. Since there were losses of proteins in 
the process of cholesterol depletion, the ratio of cholesterol to protein in the microsomes 
was measured and plotted in Figure 18 (1st panel of bars). If the amount of cholesterol in 
microsomes was expressed as a ratio to microsomal proteins, treatment with 10 mM MpCD 
was rather inefficient in removing cholesterol from the membrane; there was 82% 
cholesterol left after the 1st depletion, and 77% and 43% after the 2nd and 3rd, respectively 
(Figure 18). 
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Figure 16. Effect of MpCD on the synthesis of cholesteryl ester, triacylglycerol, and 
phospholipids. Microsome preparation with 220 |ig protein were mcubated 
with 1 mM MpCD at r.t. for 30 min. The formation of CE, TAG, and PL 
was quantitated by TLC method as described in the MATERIALS AND 
METHODS. The formation of CE is represented by bars with crosses and 
the values are scaled on the first Y axis. The formation of TAG and PL is 
represented by solid and dot bars, respectively, and the values are scaled on 
the 2nd Y axis. In all cases, the range is less than 17% of the mean. 
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Figure 17. Depletion of cholesterol by MpCD. Microsomal cholesterol of yolk sac 
membrane was depleted with different concentrations of M(3CD under 
slightly different conditions (see METHODS and RESULT). The Y axis 
represents concentration of cholesterol in i^M. In all cases, the value is a 
mean of duplicates with an error range < 6% of the mean. 
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Figure 18. Depletion of cholesterol by MPCD. Microsomal cholesterol of yolk sac 
membrane was depleted with different concentrations of MpCD under 
slightly different conditions (see METHODS and RESULT). The Y axis 
represents ratio of cholesterol to microsomal protein, ng/mg. In all cases, 
the value is a mean of duplicates with an error range < 10% of the mean. 
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Then, 25 mM MpCD was used to deplete the microsomes of cholesterol. In the 
experiment, microsomes were taken out of the -70°C freezer and thawed and stored at 4°C 
for 2 days before the depletion treatment to allow redistribution of cholesterol in 
membranes. As shown by the 2nd panel of bars in Figure 17, 28% of the original 
cholesterol was left in the microsomes after the ist depletion cycle, and 11% and 13% were 
left after the 2nd and 3rd ones, respectively. Again, when cholesterol concentration in the 
microsomes was expressed as a ratio to microsomal proteins, the depletion was rather 
incomplete (Figure 18, the 2nd panel of bars). More than half of cholesterol (54%) stayed 
in the microsomes after the 1st depletion, whereas 33% and 24% remained after the 2nd 
and 3rd, respectively (Figure 18, the 2nd panel of bars). The experiment was repeated with 
one modification in the procedure. After the 2nd depletion cycle, the resuspended 
microsomes were stored at 4°C overnight and the 3rd depletion and wash were continued 
the next day. As shown by the 3rd panel of bars in Figure 17 and 18, the overnight 
incubation made no difference in getting cholesterol out of the membrane. There was 30% 
(Figure 17) or 58% (Figure 18) of the original cholesterol left in the microsomes after the 
1st cycle, and 12% (Figure 17) or 35% (Figure 18) left after the 2nd one, and 12% (Figure 
17) or 24% (Figure 18) left after the 3rd one. 
Finally, 50 mM MpCD was used and the microsomal preparation was treated 3 
times consecutively. Microsomes were thawed and stored at 4°C for 2 days before the 
experiment. After the first cycle of depletion, only 14% of the original cholesterol was left 
in the membrane, and after the 2nd and 3rd, 6% and 4%, respectively, remained (Figure 
17, the 4th panel of bars). As shown by the 4th panel of bars in Figure 18, there was more 
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cholesterol left within microsomes if the relative amount of cholesterol to proteins was used 
to count the concentration of the sterol: 26%, 17%, and 9% of cholesterol stayed within 
microsomes after the 1st, 2nd, and 3rd depletion, respectively. 
To find out if treating microsomes with SMase could enhance cholesterol depletion, 
microsomes, which had been thawed and stored at 4°C for 2 days, were incubated with 0.12 
lU/ml SMase (0.0033 lU SMase per mg microsomal proteins) at 37°C for 30 min followed 
by 2 time depletion with 50 mM MPCD. As shown by the 5th panel of bars in Figure 17 
and 18, incubation with SMase did not change the amount of cholesterol being depleted 
from microsomes. There was 13% (Figure 17) or 29% (Figure 18) of the original amount 
remaining in the membrane after the 1st depletion and 8% (Figure 17) or 18% (Figure 18) 
remaining after the 2nd. 
To fmd out if MpCD could solubilize molecules other than cholesterol from 
microsomes of yolk sac membrane lipid, microsomes and supematant of the 1st 50 mM 
MpCD depletion were extracted with chloroform/MeOH, 2/1 v/v, and the lipid extracts 
were separated by TLC. The result of the experiment was shown in Figure 19 
(microsomes) and Figure 20 (supematant). The TLC plate of microsomes showed, within 
the detection limit, that the microsomes had cholesteryl ester, TAG, free fatty acids, 
cholesterol, PE, PS, PC, and possibly SM. It was hard to pinpoint from the TLC result the 
existence in microsomes of diacylglycerol, ceramides, and lysophospholipids. In the 
supematant, there were TAG and PC as shown in Figure 20. The existence of cholesterol 
in the supematant was not detected by the TLC method, but the amount of the sterol could 
be shown to be 318 ± 4 |j.M by a more sensitive enzymatic method (METHODS). 
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Figure 19. TLC separation of microsomal lipid components. Four himdred \ig of 
microsomal lipid, 20 mg/ml in 2/1 (v/v) chloroform/MeOH, and 20 |j.g of 
each of lipid standards were applied onto the TLC plate in alternative lanes. 
After development, the plate was visualized by I2 vapor. 
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Figure 20. TLC separation of supernatant lipid components of the 1st 50 mM MpCD 
depletion. Six hundred pig of supernatant lipid, 20 mg/ml in 2/1 (v/v) 
chloroform/MeOH, and 20 ng of each of lipid standards were applied onto 
the TLC plate in alternative lanes. In the case of MpCD, 40 ng was applied. 
After development, the plate was visualized by Ij vapor. 
supernatant 
phosphatidvlethanolamine 
supernatant 
phosphatidvlserine 
supernatant 
phosphatidylcholine 
supernatant 
sphingomyelin 
supernatant 
Ivsophosphotidylcholine 
supernatant 
methvl-B-cvclodextrin 
72 
When cholesterol in microsomes was depleted to a very low level, the ACAT 
activity in the microsomes was measured. Microsomes were taken out of the -70°C freezer 
and stored at 4°C for 2 days before the depletion experiment. Five |al treated microsomes 
were incubated with 155 ^il cholesterol-PC liposomes of different molar ratios and the 
measured ACAT SA is plotted in Figure 21 against the cholesterol mole fraction in 
cholesterol-PC liposomes. In the experiment represented by the line with open circles, 
microsomes were treated with 25 mM MpCD 3 times and then incubated with liposomes 
at r.t. for 30 min prior to the regular ACAT assay. In the experiment represented by the 
line with closed triangles, microsomes were treated with 25 mM MpCD twice and stored 
at 4°C overnight followed by the 3rd depletion and wash, and the treated microsomes were 
incubated with cholesterol-PC liposomes at 4°C overnight prior to the regular ACAT assay. 
Cholesterol stimulated ACAT activity 11 fold in the 1st experiment: 278 ± 30.6 (0.38 
cholesterol mole fraction) vs 25 ± 1.1 (zero cholesterol mole fraction) pmole/min/mg and 
17 fold in the 2nd experiment: 331 ± 9.9 (0.38 cholesterol mole fraction) vs 19 ± 1.1 (zero 
cholesterol mole fraction) pmole/min/mg. Despite the substantial increase in the specific 
activity, the enzyme was not saturated with cholesterol at the highest cholesterol 
concentration used in the experiments. 
Fifty mM MpCD was used to extract cholesterol 3 times from microsomes, which 
had been thawed and stored at 4°C for 2 days. Five ^l treated microsomes were incubated 
with 150 fil cholesterol-PC liposomes of 0.39 mole fraction in the presence of MpCD, 
added in a volume of 5 |al, at r.t. for 30 min followed by the regular enzyme assay. As 
shown in Figiare 22, the addition of MpCD stimulated ACAT activity significantly, 1462 
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Figure 21. Effect of cholesterol mole fraction on ACAT activity. Microsomes were 
taken out of the -70°C freezer and stored at 4°C for 2 days before the 
depletion experiment. Five fj,l treated microsomes were incubated with 155 
{il cholesterol-PC liposomes of different mole fractions prior to the regular 
ACAT assay. In the experiment represented by the line with open circles, 
microsomes were treated with 25 mM M(3CD 3 times and incubated with 
liposomes at r.t for 30 min. In the experiment represented by the line with 
closed triangles, microsomes were treated with 25 mM MpCD twice and 
stored at 4°C overnight followed by the 3rd treatment and wash, and the 
treated microsomes were incubated with liposomes at 4°C overnight. Each 
value is a mean of duplicates with a bar showing the range; where no bar is 
shown, it is smaller than the symbol. 
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Figure 22. Effect of MPCD on ACAT activity. Microsomes were thawed and stored 
at 4°C for 2 days. After being depleted with 50 mM MpCD 3 times, 5 |al 
of the microsomes was incubated with 150 |il cholesterol-PC liposomes of 
0.39 mole fraction plus different concentrations of MpCD, added in a 
volume of 5 nl, at r.t. for 30 min followed by the regular enzyme assay. 
Each value is a mean of duplicates with a bar showing the range; where no 
bar is shown, it is smaller than the symbol. 
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± 13.5 (1 mM MpCD) vs 154 ±1.1 (zero MpCD) pmole/min/mg, a 9.5 fold increase. With 
the same microsomes, depleted 3 times with 50 mM MpCD, the ACAT activity was 
measured after the microsomes were incubated at r.t. for 30 min with cholesterol-PC 
liposomes of different mole fractions in the absence or presence of 1 mM MpCD, shown 
in Figure 23. In the absence of MpCD, cholesterol stimulated ACAT activity 14 fold: 338 
±5.1 (0.54 cholesterol mole fraction) vs 24 ± 0.4 (zero cholesterol mole fraction) 
pmole/min/mg, while in the presence of MpCD, cholesterol stimulated the enzyme activity 
63 fold: 1395 ± 7.3 (0.39 cholesterol mole fraction) vs 22 ± 0.1 (zero cholesterol mole 
fraction) pmole/min/mg. In the presence of MpCD, the ACAT activity began to decrease 
a little bit when the cholesterol mole fraction increased from 0.39 to 0.54: 1395 ± 7.3 (0.39 
mole fraction) (100%) vs 1239 ± 12.1 (0.54 mole fraction) (89%) pmole/min/mg, whereas 
in the absence of the cyclodextrin, the enzyme activity increased 1.8 fold: 192 ± 5.0 (0.39 
mole fraction) vs 338 ±5.1 (0.54 mole fraction) pmole/min/mg. 
It turned out that 25-OH has no effect on microsomal ACAT activity of yolk sac 
membrane: 371 ± 13.8 (50 ^iM 25-OH) vs 335 ± 2.8 (1% v/v EtOH, control) 
pmole/min/mg (Figure 24). MpCD at 1 mM stimulated ACAT activity 3.7 fold, the same 
as previously shown, whether 25-OH was present or not (Figure 24). Similarly, 25-OH has 
no effect on the enzymatic activity when the depleted microsomes were assayed in the 
presence of increasing concentration of cholesterol (Figure 25). It was noticable that the 
initial ACAT activity (activity assayed with zero cholesterol mole fraction in the 
cholesterol-PC liposomes) in the depleted microsomes (Figure 25, No addition) was higher 
than that previously observed (Figvire 23, the line with the open circles), and the addition 
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Figure 23. Effect of cholesterol mole fraction on ACAT activity in the absence or 
presence of 1 mM MpCD. Microsomes were thawed and stored at 4°C for 
2 days. After being depleted with 50 mM MpCD 3 times, 5 |al of the 
microsomes was incubated at r.t. for 30 min with cholesterol-PC liposomes 
of different mole fractions in the absence or presence of 1 mM MpCD 
followed by the regular enzyme assay. The line with circles represents the 
assay in the absence of MpCD and the line with triangles represents the 
assay in the presence of 1 mM MpCD. Each value is a mean of duplicates 
with a bar showing the range; where no bar is shown, it is smaller than the 
symbol. 
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Figure 24. Effect of 25-hyciroxycholesterol on microsomal ACAT activity. Five |j.1 of 
microsomes was incubated at r.t. for 30 min with 50 25-OH and I mM 
MpCD prior to the regular ACAT assay. Stock solution of 25-OH was 
prepared in EtOH and 1% v/v EtOH was the control. Except the assay of 
microsomes represented by the solid bar, all of the rest of assay has 1% v/v 
EtOH. Each value is a mean of duplicates with a bar showing the range; 
where no bar is shown, it is smaller than the range. 
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Figiire 25. Effect of 25-hydroxycholesterol on ACAT in the depleted microsomes. 
Microsomes were depleted of cholesterol with the treatment of 50 roM 
MPCD for 3 times. Five ^1 of the depleted microsomes was incubated at r.t. 
for 30 min with cholesterol-PC liposomes of different mole fractions in the 
presence or absence of 50 pM 25-OH, or, in the presence or absence of 1 
mM MpCD before the regular ACAT assay. Each value is a mean of 
dupUcates with a bar showing the range; where no bar is shown, it is smaller 
than the symbol. 
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of 1 mM MpCD increased the initial activity further. In the experiment depicted in Figure 
25, the microsomes were thawed from -70°C and used right away for depletion treatment 
without a pre-storage of 2 days at 4°C, which was done with previous experiments (Figure 
17-18 and Figure 21-23). The storage at 4°C was shown to lead to cholesterol 
redistribution and ACAT activation in microsomes, and the very low initial activities 
observed in the previous experiments were probably because the residual amounts of 
cholesterol in the depleted microsomes were not in the substrate pool and not available for 
esterification. Without the pre-redistribution of cholesterol at 4°C for 2 days, the residual 
amount of cholesterol after depletion, 4% of the original sterol concentration in the 
microsomes, was perhaps more accessible to the enzyme, causing a higher initial activity 
(Figure 25). 
B. Discussion 
1. Comparison of ACAT from avian and mammalian sources 
The function of ACAT in the yolk sac membrane is to convert cholesterol and fatty 
acids in the yolk to cholesteryl esters, which can be packaged into lipoproteins and secreted 
into circulation. The esterification facilitates the absorption of the sterol and free fatty 
acids and the presence of esters in lipoproteins stabilizes the assembly and structure of the 
particles [7]. Thus, the enzyme functions significantly in providing essential lipid nutrients 
to the developing embryo, not only as a source of energy, but also as essential membrane 
components and vitamins [6,7]. Under this particular circumstance, in which the 
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physiological role of the enzyme is to support and nourish development, a sustained and 
high activity in the yolk sac membrane is desired. On the other hand, ACAT in the liver 
plays more of a regulatory function, converting excess free cholesterol to esters and 
preventing any toxic effect of the sterol. The liver protem may be more sensitive to 
changes in its environment and be subject to modification and inactivation. The higher 
specific activity found in the yolk sac membrane [6] and better stability upon storage 
provided a suitable system for the study of ACAT. Compared with the enzyme in the liver, 
intestine, and adrenal cortex under normal physiological conditions, more than 5 fold higher 
ACAT activity was reported in yolk sac membranes of chicken eggs 16 days after 
fertilization [6]. Microsomes prepared from yolk sac membranes after storage at -70°C for 
6 months had active ACAT, while mouse livers stored in the same way for 3 months 
contained inactive enzyme when made into microsomes (data not shown). Deoxycholate 
extracts from mouse liver microsomes had to be used within 2 days of preparation to have 
active enzyme for ftmctional analyses [3], whereas about 80% of the initial ACAT activity 
remained after storage at 4°C for 3 weeks for CHAPS-solubilized extracts from yolk sac 
membrane (data not shown). The difference in the properties of the detergents themselves 
(deoxycholate is anionic while CHAPS is zwitterionic) may play a part in the difference 
in stability, but the intrinsic properties of the enzyme from different sources are probably 
more important in maintaining the stability. Characterization of ACAT from yolk sac 
membrane is, therefore, biologically significant, and the avian enzyme provides some 
advantage over the mammalian equivalent in the study of the protein. Similar to the 
mammalian enzyme [44,45], ACAT of yolk sac membrane is sensitive to inhibitions by 
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DEPC and PMB (Figure 1 and 2). A close examination of the profiles of DEPC and PMB 
inactivation revealed a closer resemblance of the avian enzyme to that of aortic subtype, 
with regard to the sensitivity towards chemical modification, rather than that of the liver 
subtype in rabbits [44,45]. For example, treatment of microsomes with 500 |iM DEPC 
inhibited 90% of the activity for the avian enzyme (Figure 1) and fully inactivated the 
rabbit aortic AC AT [44], while the same treatment of rabbit liver enzyme led to a inhibition 
of only about 25% [44]. Complete inhibition of the liver enzyme by DEPC required 10 
fold higher concentration [44]. Likewise, ACAT from yolk sac membrane (Figure 2) and 
rabbit aorta [45] was completely inactivated by treatment with 500 |iM PMB, whereas the 
liver enzyme retained about 75% of its activity [45]. In the treatment of microsomes with 
different concentrations of PMB, the enzyme of yolk sac membrane (Figure 2, insert) and 
of rabbits [45] both showed an increase in the activity followed by complete inactivation. 
Therefore, the structure and regulation of the avian enzyme may very likely be comparable 
to that of mammalian origin and study of the former can provide useful information about 
the latter. 
The focus of the present study is to characterize ACAT from yolk sac membrane 
of chicken eggs after fertilization and compare the properties of the avian enzyme with that 
from mammalian sources. Although abundant information has been learned about 
mammalian ACAT using molecular biology techniques, direct biochemical study of the 
enzyme has not been achieved with the pure protein. Studies of regulation of ACAT 
activity, e.g. by cholesterol supply, by 25-hydroxycholesterol, and other oxysterols, have 
been conducted in microsomal preparations or detergent extracts. Purification of the protein 
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of the avian source was attempted in the early part of this work, but instability of the 
enzyme activity and sensitivity towards its surrounding environment prevented successful 
purification. Detergent solubilization followed by ammonium sulfate precipitation and 
column chromatography using individual or combinations of size permeation, ion exchange, 
activated thiol Sepharose, and hydrophobic interaction (Phenyl Sepharose and Propyl 
Agarose) columns and preparative lEF failed to yield the active enzyme. In her 
dissertation, M. Shih [3] discussed and justified the method of preparing and assaying 
ACAT of mouse liver microsomes, and adaptation of her method of measuring the enzyme 
activity to the avian system works satisfactorily. Measurement of the ACAT activity in 
microsomal preparations or detergent extracts becomes the only way to characterize the 
enzyme in the current study. 
From the cDNA sequence, the human macrophage ACAT is deduced to have 9 
cysteine residues [4]. At least one cysteine should exist as thiol (SH) without engaging in 
a covalent linkage if no intermolecular disulfide bonds are formed between one ACAT 
molecule and another ACAT or other proteins. Depending on where the thiol is located 
on the protein, a hydrophilic environment close to the surface of the protein or hydrophobic 
surroundings buried inside, it may be subject to chemical modifications that may or may 
not affect enzyme catalysis. Modification of ACAT of yolk sac membrane by thiol-reactive 
agents revealed some very interesting properties of the avian enzyme. When the enzyme 
was treated with low concentrations of PMB, NEM, and NBM, increases in ACAT SA 
were observed (insert in Figure 2, Figure 3 and 4). Elevation in the activity was 
consistently seen in treatments of microsomes with I AM, and higher concentrations of LAM 
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produced bigger increases (Figure 3). High concentrations of PMB and NBM inhibited the 
enzyme completely (Figure 2-4). It is likely that, at low concentrations, PMB and NBM 
reacted with thiols that were easily accessible and quite reactive, and the modification of 
those sulfhydryls altered the protein conformation such that the enzyme became more 
active. Alternatively, some unidentified factors might exist in the lipid bilayer and their 
modification leads to changes in the membrane fluidity and enzyme activity. High 
concentrations of PMB and NBM led to modification of more SHs, reactive or less reactive, 
easily or not easily accessible, and inactivated the enzyme. As shown in Table 1, a very 
small fi-action of the total microsomal thiols reacted with lAM at 20 mM, and an even 
smaller fraction of them reacted with PMB at 20 |iM. The elevation in ACAT activity seen 
in Figiu*e 2-4 can be the consequence of modification of a few thiols, exposed or peculiarly 
located on the protein, causing a positive alteration in protein conformation. A rise in 
ACAT activity prior to inactivation upon PMB modification was also observed in 
microsomal preparations firom rabbit liver and aorta [45], probably due to the same reason 
as it is in the yolk sac membrane. 
Another interesting feature about the avian enzyme is that the thiol(s) involved 
directly or indirectly in catalysis may sit in a non-polar vicinity, as suggested by the result 
listed in Figure 3 and 4. lAM or NEM at 20 mM did not inhibit ACAT activity, while at 
the same concentration, NBM, the more hydrophobic analog of NEM, inactivated the 
enzyme completely. The hydrophobic molecule PMB inactivated ACAT at concentrations 
as low as 100 |iM. lAM and NEM are hydrophilic molecules, their reactivity towards 
exposed surface sulfhydryls is much greater than to hydrophobic or buried SH(s). On the 
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other hand, hydrophobic reagents like PMB and NBM penetrate better into the inside of 
proteins and their reactivity towards buried or hydrophobic sulfhydryls is much bigger. 
Failure to protect ACAT activity with preincubations of I AM or NEM against treatments 
of PMB or NBM indicates that the siilfhydryl(s) modified by PMB and NBM must come 
from cysteine(s) that were different from those that reacted with lAM and NEM. It is 
tempting to propose that ACAT protein has at least two categories of thiols, distinct by the 
environments they occupy and by the opposite effect on catalysis brought about upon their 
modification. One group of thiols is located in polar regions, vulnerable to modification 
by hydrophilic reagents and capable of inducing enzyme activity after being modified. The 
other group sits in non-polar environments, susceptible to chemicals that are hydrophobic 
and modification of them causes inhibition. The reaction ACAT catalyzes involves one 
amphipathic (acyl-CoA) and two hydrophobic molecules (cholesterol and cholesteryl ester), 
the active site of the enzyme and the area around it should be quite non-polar. The data 
generated from chemical modification of ACAT are in good agreement with the scheme 
predicted about ACAT. 
Table 1 lists the amount of total thiols in yolk sac membrane microsomes and the 
fractions of sulfhydryls that are reactive towards sulfhydryl-modifying agents. About 40% 
of the total thiols are not available for modification by sulfhydryl-blocking reagents, even 
with NBM at 20 mM. Those thiols must be buried deep inside protein structures and can 
not be approached easily. Although PMB at 100 |iM reacted with a much smaller fraction 
of sulfhydryls than NBM at 20 mM did, both of them inactivated the enzyme completely. 
It is probable that the structure of PMB, with a planar benzene ring, fits better the geometry 
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of the site(s) where thiol(s) are formed, resulting in inhibition at a much lower 
concentration. 
Inactivation of ACAT by thiol-reactive agents does not prove the direct participation 
of cysteine(s) in catalysis. Loss of catalytic activities by treatments of enzymes with 
sulfhydryl-modifying chemicals can be the consequence of blockage of thiols functioning 
directly in catalysis, however, steric hindrance to substrate binding by the modification of 
thiols in the vicinity of the active site or conformational change induced by the attachment 
of modifying groups onto proteins would lead to destruction of catalytic ability, too. LCAT 
is a perfect example showing the influence of noncatalytic thiols on enzyme activity. In 
LCAT, cysteines 31 and 184 do not participate in catalysis, but their modification poses 
steric restraint to substrate binding because of their location near the active site [49,50]. 
Once the pure protein is available, the role of cysteines in ACAT catalysis can be studied 
and might be shown to be just like that in LCAT. 
Like the mammalian enzyme activity, ACAT from yolk sac mambrane can be 
extracted into detergent, deoxycholate or CHAPS, solutions (data not shown). The best 
concentration for CHAPS was found to be 0.5% (w/v) (Figure 5). The effect of NaCl on 
ACAT SA in both extract and pellet (Figure 6A and B) could come from an increase in 
ionic strength in the presence of the salt, causing solubilization of more peripheral proteins 
and making the disintegration of microsomal membranes more efficient. Another 
probability is that the presence of the salt stabilizes the structure of ACAT in the detergent 
micelles, leading to a higher recovery of the activity when assayed. 
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ACAT SA in the CHAPS extract decreases gradually as the number of thiols being 
reacted with DTDP increases (Figure 7). There was not a single concentration of DTD? 
at which the enzyme activity dropped sharply. 
Even though ACAT from yoUc sac membrane and mammalian sources shares many 
common features with regard to inhibition by histidine- and cysteine-reactive agents, there 
are subtle differences in the sensitivity towards modification. It turned out that the enzyme 
activity in mouse liver microsomes was more vulnerable to modifications by thiol-reactive 
agents (Figure 8), compared with the avian enzyme (Figure 3). As shown in Figure 9A, 
2-Mer has little effect on the enzyme activity from both sources, and it can recover most 
of the activity of yolk sac membrane (87%) from the pretreatment of microsomes with 
PMB, but it is incapable of rescuing the enzyme of mouse liver (6%). BdiT is a molecule 
of higher hydrophobicity, compared with 2-Mer, and has a pair of SHs. By itself, BdiT has 
an inhibitory effect on ACAT from both systems, presumably it can react with the same 
sulfhydryl(s) as PMB does, resulting in a loss of enzyme activity. After preincubation of 
microsomes with PMB, treatment with BdiT recovered the majority of mouse liver activity 
(69%) while stimulating the yolk sac membrane enzyme (141%). One of the possibilities 
for the activation of ACAT from yolk sac membrane upon the sequential treatment of PMB 
and BdiT is that BdiT reacts with two kinds of thiols, modification of the first leads to an 
activation of the enzyme, whereas modification of the second causes inhibition. The 
inhibition observed in BdiT alone treatment is the net outcome of the two opposite effects, 
and in the case of pretreating microsomes with PMB, BdiT releases the inhibitory thiol(s) 
from PMB blockage, so the net outcome now is a stimulated activity. In conjunction with 
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the result showing higher sensitivity towards NBM treatment (Figure 8), the result of the 
experiments shown in Figure 9 indicates that, in the mouse protein, the thiol(s) associated 
directly or indirectly with catalysis is located in a more hydrophobic vicinity than that in 
the avian enzyme, and release of the SH(s) in mouse liver microsomes requires non-polar 
molecules like BdiT. 
The PMB-BdiT experiment (Figure 9B) was repeated several times during the 
investigation, a complete inhibition of ACAT by PMB could not be achieved, even though 
exactly the same procedures were followed in the preparation of the microsomes and PMB 
solutions in both PMB-2-Mer (Figure 9A) and PMB-BdiT (Figure 9B) experiments. There 
is no good explanation for the different efficacies of ACAT inhibition by PMB (Figure 7A 
and B), except the possible differences in the batches of microsomes and PMB stock 
solutions used. 
The effect of cholesterol hydroperoxides on mouse liver ACAT was studied in detail 
by M. Shih [3], and HP-B was found to have a complete and irreversible inhibition on the 
microsomal enzyme (Table 2). Oxidation of methionine residue(s) in the mammalian 
enzyme was suggested [3]. The enzyme from yolk sac membrane, on the contrary, was 
much less sensitive to oxidation by HP-B, and the lost activity could be recovered 
completely by DTT. 
2. Effect of cholesterol redistribution on ACAT activity 
It is known that cellular membranes are not homogeneous structures of randomly 
distributed lipids with embedded proteins. Rather, they contain microorganizations that 
differ from each other by the size of domains, by lipid and protein compositions, and by 
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the kinetic movement of each component [88]. Cholesterol-rich and cholesterol-poor 
domains are shown to exist in the lateral plane of the membrane and the distribution of the 
sterol in the two leaflets of the bilayer and among different membrane compartments is 
known to be asymmetrical [88]. Transport of the sterol among different membrane 
structures and maintenance of the gradient of cholesterol in the cell require lipid carrier 
proteins and transporting vesicles. Upon breaking-up of the cell and subsequent cellular 
fractionation, the non-equilibrium condition of cholesterol is disrupted, and redistribution 
of cholesterol among membrane fragments may now be able to proceed consequently. 
Cholesterol redistribution in the microsomes of yolk sac membrane turned out to activate 
ACAT considerably and made a very interesting case in the study of the enzyme. 
Following is a series of experiments designed to dissect the mechanism of ACAT activation 
upon storage at 4''C. 
A short-lived protein inhibitor of ACAT has been reported in mammalian cells and 
the inhibitor is susceptible to proteolytic cleavage by cysteine proteases [55-58]. The 
nearly two fold increase in ACAT activity observed during the first two days of the 4°C 
storage experiment could be due to the destruction of an intrinsic ACAT inhibitor, if it also 
exists in the microsomes of yolk sac membrane and its loss happened much faster than the 
inactivation of the enzyme itself, resulting in the elevation of the activity seen in Figure 10 
and 11. To examine the possible action of any cysteine proteases that may exist in the 
microsomal preparation, ALLN, a neutral cysteine protease inhibitor, was added to the 
microsomes at the begirming of the experiment (Figure 12). Apparently, ALLN did not 
affect the activation process because the microsomes had very similar ACAT activity in the 
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absence or presence of ALLN. Since the time course experiments described above were 
carried out in air, there was a possibility of oxidative inactivation of the putative ACAT 
inhibitor, which might have thiol(s) that were susceptible to oxidation. From the present 
work and Chang's work [34], it is known that ACAT activity of any sovirce is not 
influenced by the presence of DTT. As one can see from Figure 13, the inclusion of the 
sulfhydryl protecting agent did not change the course of activation, and it helped sustain 
the activity a little bit higher. Therefore, either the yolk sac membrane does not have an 
intrinsic protein inhibitor to regulate ACAT activity, or the putative inhibitor does not 
partition into the microsomes when the microsomes are prepared, or the factor is not 
susceptible to cleavage by cysteine proteases. In any case, the activation of ACAT 
observed in the 4°C storage experiments can not be explained by the results of the 
experiments aimed at exploring any inhibitory factor(s) of ACAT in the yolk sac 
microsomes. 
Another possibility for the increase in ACAT SA during storage at 4°C is a change 
in the microsomal membrane structure that affected the enzyme activity. It is knovra that 
the structure and fluidity of lipid bilayers affect activity and properties of membrane-
associated proteins, including enzymes, receptors, and transporters [89-92], and oxidation 
of the lipids, phospholipids as well as cholesterol, can change membrane fluidity and 
microheterogeneity [93-96]. Lipids in lipoproteins are susceptible to oxidation, mediated 
by either the cells in the blood vessel wall or metal ions in circulation, and oxidation of 
lipids leads to changes in both lipid and protein structures [97]. In the majority of literature 
on lipoprotein oxidation, CUSO4 has been used as a catalyst for oxidation. Examination of 
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microsomal oxidation catalyzed by 5 jiM CUSO4 revealed no elevation in ACAT activity 
(Figure 14B) (actually, a little bit of decrease in the activity was observed), and storage of 
microsomes at 4°C overnight resulted in 150% increase in ACAT activity, probably due to 
the same mechanism that increased the enz3Tne activity as depicted in Figure 10-13. 
Hydrogen peroxide is known to react with sulfiir-containing amino acids, i.e., cysteines and 
methionines, in proteins, and under certain circvunstances, it also reacts with tryptophans, 
tyrosines, and cystines [98]. Oxidation of microsomes using increasing concentrations of 
HiO, did not affect ACAT activity (Figure 14A). Among other factors that affect 
membrane structure, hydrolysis of membrane complex lipids by lipases results in the 
formation of free fatty acids, lysophospholipids, diacylglycerols, ceramides, etc., and the 
formation of these minor membrane lipid molecules affects bilayer packing and 
microheterogeneity, which in turn affects enzymes embedded in it [99,100]. DAG is 
known to act as an intracellular second messenger and activate protein kinase C and the 
following signaling pathways [101]. The role of sphingomyelin-derived second messengers, 
especially ceramides, in intracellular signal transduction has been realized more recently, 
and their involvement in regulation of cell proliferation, differentiation, and apoptosis is 
becoming more clear [102-109]. These lipid molecules generated fi-om hydrolysis of 
complex lipids in the plasma membrane interact with a variety of proteins and kinases and 
induce various processes inside the cell. Inhibition of ACAT activity by short-chain 
ceramides and dihydroceramide was reported in CHO cells [110]. Treatment of 
microsomes of yolk sac membrane with linolenic acid, DOG, ceramides, and DHS had little 
or no effect on ACAT activity (Table 3). In the case of treatment of microsomes with 
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lysoPC, the lower-than-control enzyme activity is probably due to a competition of lysoPC 
v(dth cholesterol for acyl-CoA, lowering the effective concentration of the other substrate 
of ACAT. The effect on lipid bilayers and membrane proteins brought by oxidation of 
microsomes or the addition of minor membrane lipids may not be big enough to influence 
ACAT activity, and responses induced by second messengers may require intact cells for 
the whole pathway(s) to ftmction. On the other hand, ACAT from the yolk sac membrane 
may not be very sensitive to any changes in the global environment of the lipid bilayer. 
Early studies on dietary feeding of whole animals with different compositions of fatty acids 
suggested that membrane fluidity and lipid composition influenced hepatic and intestinal 
ACAT activities [1]. The insensitivity of the avian enzyme to the treatments affecting 
membrane structure may reflect the subtle difference m the physiological functions of the 
enzyme under different circumstances. Failure to reproduce the ACAT activation seen in 
the experiments depicted in Figure 10-13 by disturbance of microsomal membrane structure 
or addition of the second messengers suggests that changes in the lipid bilayer and 
membrane proteins may not be the mechanism that caused the activation, and signaling 
effect of second messengers may require a whole network of factors that are only present 
in the intact cells. 
There has been mounting evidence that under physiological conditions, ACAT is not 
saturated with substrate cholesterol and addition of exogenous cholesterol to microsomes 
can increase the synthesis of cholesterol esters. Without adding cholesterol exogenously, 
J. Corton and D. Hardie showed that redistribution of endogenous cholesterol among 
microsomal vesicles could increase ACAT activity and in their case, sterol carrier proteins 
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were the possible factors that induced and facilitated the redistribution [54]. The activation 
of ACAT observed in the 4°C storage experiment could be due to a redistribution of 
cholesterol in the microsomes during the storage period, and the redistribution led to an 
increase in the ACAT substrate pool, resulting in the activation seen in the first 2 days of 
the experiment. To test the hypothesis, any factor that can help move cholesterol among 
membrane vesicles would be very useful in delineating the mechanism. 
Cyclodextrins are cyclic molecules composed of different number of glucose units. 
With a hydrophilic surface and hydrophobic interior, cyclodextrins can form inclusion 
complexes with hydrophobic molecules and enhance the solubility of lipophiles in aqueous 
solutions [111]. Utilization of cyclodextrins in delivery of non-polar drug molecules and 
supplementation of natural lipid carriers in circulation and cell cultures has been very 
important in pharmaceutical, clinical, and basic research [112-115], and the usefulness of 
these lipid-solubilizing sugar oligomers in cholesterol research is becoming more 
significant. Studies of reverse cholesterol transport and intracellular cholesterol trafficking 
use cyclodextrins as effective cholesterol acceptors [116-119]. Among the commercially 
available cyclodextrins, p-cyclodextrin with 7 glucose units is the most effective molecule 
to solubilize cholesterol from lipid bilayers [8,9]. Cyclodextrins themselves are quite toxic 
to animals and their solubilities in aqueous solutions are limited. Derivatives of 
cyclodextrins have been synthesized chemically and found to be much less toxic and more 
soluble [113]. In their study of reverse cholesterol transport, P. Yancey et al found that the 
methyl derivative of P-cyclodextrin was more effective than the 2-hydroxypropyl derivative 
or P-cyclodextrin itself in extracting cholesterol from the plasma membrane of mouse L-cell 
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fibroblasts [116]. Not only are cyclodextrins used as acceptors in cholesterol depletion 
experiments, complexes of cholesterol with cyclodextrins can efficiently provide the sterol 
to membranes or cells in cholesterol repletion experiments [10,120]. Addition of MpCD 
to microsomes turned out to enhance ACAT activity greatly, nearly a 4 fold increase in 
ACAT SA (Figure 15). The formations of TAG and PLs, processes involving other ER 
membrane-associated enzymes in microsomal fractions and acyl-CoA as the other substrate, 
did not change significantly (Figure 16). It is known that the cellular membranes are 
heterogeneous structures of lipid and protein microdomains and cholesterol-rich and 
cholesterol-poor domains are distinct structural and kinetic organizations [88]. The results 
of these experiments indicate that MpCD can shuffle cholesterol around among microsomal 
fragments, from cholesterol-rich microdomains to cholesterol-poor microdomains, or from 
non-ACAT substrate pools to the ACAT substrate pool, and the enhanced redistribution of 
cholesterol resulted in increased enzyme activity (Figure 15). In agreement with the 
suggestion that a change in ACAT substrate pool size, not changes in microsomal 
membrane structure, affected ACAT activity, activities of the enzymes that are membrane-
embedded and catalyze the formations of TAG and PLs did not change significantly (Figure 
16). Thus, redistribution of cholesterol among microsomal vesicles during the storage 
period was very likely the mechanism that increased ACAT activity seen in the first two 
days of the experiments (Figure 10-13). During the course of this study, M. Liza et al 
reported an about 4 fold activation of rat liver microsomal ACAT in the presence of 6 mM 
2-hydroxypropyl-p-cyclodextrin and explained the activation as a result of the facilitated 
redistribution of cholesterol in the presence of the cyclodextrin molecule [121]. Therefore, 
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cases of increases in ACAT activities by the effect of cholesterol redistribution may be 
quite general. The reason it has not been reported earlier could be that, most of the time, 
people study the enzyme from mammalian cells, and the mammalian enzyme is not very 
stable under storage, not stable enough to show an increase in the activity first before being 
inactivated. Other times, people just do not recognize the situation. In one incidence, 
Chang et al observed a nearly 2 fold increase in ACAT activity when they compared the 
cell extracts incubated for 30 min at 37°C with that at 4°C [5]. There was no explanation 
by the authors for the observed enzyme activation, but it is very plausible to suggest that 
a faster redistribution of cholesterol at the higher temperature was the factor leading to the 
increase. The property and stability of ACAT of yolk sac membrane allows the study of 
the minor but very interesting situation. 
The activation of ACAT by redistribution of cholesterol in the absence of MpCD 
did not exceed two fold under any conditions studied (Figure 10-13 and Figure 14B), while 
in the presence of the cyclodextrin, an around four fold increase in the activity was 
consistentiy observed (Figure 15-16). Inactivation of the enzyme prior to the full activation 
was not the reason for the lowered activation because, as shown in Figure IIC, ACAT had 
been staying active for about 4 days before beginning to lose the activity. Even though any 
cellular cytosolic factor(s) that establishes and maintains the non-equilibium condition of 
cholesterol in the cell was removed or destroyed during the preparation of microsomes, 
some lipid or protein factors, which also help maintain microdomains of cholesterol in 
membranes, might exist in lipid bilayers and remain functional through the preparation. 
The interaction of cholesterol with those factors may restrain the movement of the sterol 
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from a complete random redistribution among membrane fragments. In other words, the 
association of cholesterol with the non-ACAT substrate pool limits the movement of the 
sterol, lowering the fiill potential of cholesterol to activate the en2yme. The formation of 
the inclusion complex with MPCD shifts the equilibrium towards the ACAT substrate pool, 
leading to a higher degree of enzyme activation. Thus, the use of the cyclodextrin in the 
study allows the understanding of ACAT activation upon storage and reveals the possible 
fiill potential of activation of the en2yme by endogenous cholesterol m cellular membranes. 
3. Regulation of ACAT activity by (oxy)sterols 
Studies on regulation of ACAT by cholesterol have been done previously on 
different systems and conditions, but the majority of them focused on the enzyme from 
mammalian sources and a lot were not in detail and complete. Taking the advantage of low 
concentration of intracellular cholesterol and lack of endogenous ACAT activity in insect 
Sf9 cells, Chang et al were able to express the human ACAT ftinctionally and demonstrate 
the allosteric effect of cholesterol on the enzyme [5]. However, it appeared that the human 
enzyme could be saturated with cholesterol at relatively low concentration. At about 0.10 
mole fraction of cholesterol, the enzyme activity reached a maxinum [5]. According to P. 
Yeagle's report [122], plasma membranes normally contain about 45 mol% of cholesterol 
and ER membranes have 10-12 mol% of the sterol. Chang et al's result implied that under 
normal physiological conditions, ACAT was saturated with cholesterol, which was 
contradictory with the majority of the literature reports. 25-Hydroxycholesterol has been 
shown to activate ACAT in mammalian cells, microsomal preparations, and cell extracts 
[3,5,46,71-74], and the activation mechanism was sought after in the works of Chang et al 
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[5] and Bhuvaneswaran [72]. No definite conclusion was drawn from their works. 
Regulation of ACAT of yolk sac membrane by cholesterol and 25-OH was explored in the 
current work and summaried in the following section. 
To study the avian ACAT in relationship to cholesterol and oxysterols, microsomes 
of yolk sac membrane were depleted of cholesterol after repeated treatments with MpCD 
of different concentrations. As shown in Figure 17, higher concentrations of MpCD 
solubilized more cholesterol from the membrane. With 10 mM MpCD, a little bit less than 
half the amount of the initial sterol remained after 1st depletion and about one fourth 
remained after the 3rd (the 1st panel of bars in Figure 17), but with 50 mM MpCD, less 
than one sixth the amount of the initial sterol remained after the 1st depletion and only 4% 
remained after the 3rd (the 4th panel of bars in Figiire 17). Loss of microsomal proteins, 
the majority of which probably were peripheral instead of integral membrane proteins, was 
observed in the process of cholesterol depletion (data not shown). Apparently, 
concentration of MpCD is an important factor determining the percentage of cholesterol 
being extracted, no matter how the content of cholesterol is expressed (as concentration in 
|aM, Figure 17, or as a ratio to microsomal proteins. Figure 18). Two kinetic pools of 
cholesterol, a fast pool and a slow pool, were observed in the plasma membranes of several 
cell types when reverse cholesterol transport was studied in cell cultures [117]. The fast 
pool could be restored with cholesterol after a recovery time, presumably through the 
redistribution of the sterol in membranes. Smce the redistribution of cholesterol was shown 
to happen among microsomal vesicles, it might be possible that more sterol could be 
depleted out if sufficient time was allowed for the redistribution. Overnight incubation of 
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the microsomes at 4''C after two cycles of depletion did not make any difference in the 
extent of cholesterol being extracted (the 3rd panel of bars in Figure 17 and 18). The 
amount of cholesterol in the plasma membrane has been shown to correlate positively with 
that of sphingomyelin and hydrolysis of the sphingolipid by SMase leads to a loss of 
cholesterol in the membrane [63-69]. Treatment of microsomes with SMase before the 
depletion cycles did not change the amount of cholesterol being solubilized (the 5th panel 
of bars in Figure 17 and 18). It appears that the extent of cholesterol solubilization 
depends only on the concentration of the cyclodextrin used, other factors that affect 
cholesterol redistribution do not play a role. 
Besides cholesterol, p-cyclodextrins can solubilize cholesteryl esters, TAGs, PLs, 
and sphingomyelins, even though the magnitudes of extraction are much smaller [8,9]. 
Consistent with the literature, TAG and PC were found in the supernatant of the 1st 50 mM 
MPCD depletion (Figure 20). 
Depletion of microsomal cholesterol with treatments of 25 mM MpCD for three 
times lowered cholesterol content in the microsomes to 0.042 (the line with open circles. 
Figure 21) and 0.026 (the line with dotted circles. Figure 21) mole fraction of total lipids 
(PLs plus cholesterol) in microsomes. In the ACAT assay, the depleted microsomes were 
mixed with liposomes, so the cholesterol concentration would be even lower, 0.0018 (the 
line with open circles) and 0.0015 (the line with dotted circles), because the liposomes 
contained no cholesterol (the first point in the plot). When the depleted microsomes were 
assayed for ACAT activity after incubation with cholesterol-PC liposomes of increasing 
cholesterol mole fractions at r.t. for 30 min (the line with open circle) or at 4°C overnight 
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(the line with dotted circles), the enzyme SA increased progressively, without reaching a 
plateau (Figure 21). At the highest concentration used, 0.38 mole fraction, and with 
overnight incubation with the liposomes, ACAT was not saturated with cholesterol. 
Normally in the cell, the ER membranes are shown to contain 10-12 mol% of cholesterol 
[122]. Cholesterol mole fraction in microsomes of yolk sac membrane was measured to 
be from 0.099 to 0.12, in very good agreement with the literature. At around 0.10 mole 
fraction of cholesterol, the human macrophage ACAT activity was shown to reach a plateau 
[5], the same was true for the mouse liver enzyme except at a higher cholesterol mole 
fraction (about 0.3) [3]. Perhaps, the avian enzyme had a very high Km such that it would 
not be saturated easily with high sterol concentrations, or, the increase in membrane rigidity 
or some structural changes brought by increasing concentrations of cholesterol favored the 
catalysis. The first possibility sounded unreasonable considering the fionction of the 
enzyme in yolk sac membrane, efficient conversion of substrate to product, meaning 
smaller Km, would provide cholesteryl esters for lipoprotein assembly more effectively. 
The second possibility might work in the case of this enzyme for its unique property and 
fimction. A third possibility for not being able to saturate the enzyme was that the transfer 
of cholesterol from cholesterol-PC liposomes to microsomes was slow, limiting the access 
of the sterol to ACAT substrate pool. When microsomal cholesterol was depleted to 0.016 
mole fraction of total lipids (PLs plus cholesterol) in microsomes with treatment of 50 mM 
MpCD (0.0012 mole fraction in the ACAT assay when the microsomes were mixed with 
liposomes containing no cholesterol) (the first point in the plot. Figure 23), the enzyme was 
assayed in the presence of MpCD. Since MpCD is known, from above results, to be 
capable of facilitating cholesterol redistribution among microsomal vesicles, it should 
enhance the transfer of cholesterol from liposomes, the source of substrate, to the 
microsomes, the site of enzyme catalysis. Indeed, an increase in M|3CD concentration 
increased ACAT SA significantly, and the activity approached a plateau as the MPCD 
concentration reached 1 mM (Figure 22). When the depleted microsomes were assayed 
with liposomes of increasing cholesterol mole fractions in the presence of 1 mM MpCD, 
the enzyme activity reached a maximum around 0.4 cholesterol mole fraction (the line with 
circles. Figure 23). Thus, failure to saturate the enzyme with physiologically high limit of 
cholesterol (Figure 21 and the line with circles in Figure 23) is the result of limitation of 
substrate availability, and the use of MpCD accelerated transfer of cholesterol from 
liposomes to the enzyme substrate pool and eliminated the restraint of slow transfer of the 
substrate. 
The shape of the ACAT activity vs cholesterol mole fraction curve is sigmoidal 
(Figure 23, the line with the triangles), suggesting allosteric interaction of cholesterol with 
ACAT. In his book, I. Segel discussed schematically enzymatic catalyses that show 
sigmoidal enzyme vs substrate profiles [123]. Cooperative interaction between an enzyme 
and its substrate shows sigmoidicity in the activity vs substrate concentration plot and is 
best explained mathematically by Hill equation and plot [123]. 
V [S]n 
= Hill equation 
Vmax K' + [S]n 
where v is enzyme activity, is the maximal activity, [S] is substrate 
concentration, K' is a constant consisting of interaction factors and 
the intrinsic dissociation constant, and n. Hill coefficient, is the 
number of substrate binding sites for each enzyme molecule. 
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Fitting of the data to Hill equation gave a Hill coefficient of 2.1 ± 0.4 (Figure 26). 
This suggests that the avian enzyme has multiple, possibly two, binding sites for 
cholesterol, and binding at one site enhances binding at the other site and causes a change 
in the conformation of the enzyme such that a more active state of the enzyme results. It 
is not known jfrom current data if ACAT works as a monomer with multiple binding sites 
or as an oligomer of multi-subunits. The human macrophage enzyme was deduced to be 
65 kDa [4], but antibodies of ACAT interacted with bands of higher molecular weights on 
Western blots [5,37]. Analysis of the deduced ACAT sequence revealed the existence of 
a dimerization motif [4], and radiation inactivation experiments indicated the functional size 
of rat liver ACAT to be 170-180 kDa [35] or 213 ±35 kDa [36]. Plenty of evidence 
suggests that ACAT can oligomerize and may flmction as an oligomer, however, a definite 
answer can be assured only when the protein is purified and studied in homogeneity. In 
mammalian systems, sterol-mediated activation of ACAT is understood as being regulated 
not at the transcriptional and translational levels, but at posttranslational step(s) [42,37,70-
71]. For the enzyme from both human macrophages [5] and mouse liver [3], cholesterol 
was shown to interact with ACAT cooperatively and act as an allosteric activator as well 
as a substrate [3,5]. In the current work, ACAT from yolk sac membrane of chicken eggs 
16 days after fertilization is shown to response sigmoidally to increasing cholesterol mole 
concentration possibly through an allosteric effect of the sterol. 
A sigmoidal profile of activity vs concentration is characteristic of cooperative 
substrate binding during enzyme catalysis, but cases do exist where a catalysis showing 
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Figxire 26. Fitting to Hill equation. Experimental data shown in Figure 23 (ACAT SA 
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the calculated curve fit the data. 
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sigmoidicity is not associated with substrate-enzyme cooperative interaction [123]. I. Segel 
discussed this kind of reactions as follows [123]: 
^ A 
E EA 
B I B 
' I 
A, E B  — E A B  ^  p r o d u c t s  
In a Random Bi Bi reaction of enzyme E with substrates A and B, if the formation 
of EAB complex is much slower than the conversion of EAB to products and if one route 
to form E.^B complex is more favored than the other, then the profile of velocity vs 
concentration of one substrate will be sigmoidal. In a reaction like this, sigmoidicity does 
not indicate allosteric interaction between an enzyme and its substrate. The mechanism of 
ACAT catalysis is not known, neither are the association constants of ACAT binding to 
cholesterol and to acyl-CoA, thus, the possibiUty of slow bindings of cholesterol and acyl-
CoA to ACAT proceeding a fast formation of cholesteryl ester cannot be ruled out in the 
avian system. In any case, the sigmoidal shape of SA vs concentration of the avian enzyme 
suggests it may act quite similarly to its mammalian coimterparts, interacting with substrate 
cholesterol specifically. 
The significance of the usage of M(3CD in the study of ACAT-cholesterol 
relationship was clearly demonstrated by the saturation of ACAT in the presence of the 
cyclodextrin compared with that in the absence (Figure 23). The ACAT assay solution was 
a mixture of microsomal vesicles and small-size unilamellar liposomes (in the extrusion 
device used to prepare liposomes, membrane pore size was 100 nm), encounter of 
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cholesterol in the liposomes with ACAT on the ER membrane could be achieved by two 
ways (cholesterol in the microsomal membrane was depleted to about one tenth of the usual 
content in ER membrane, so the major supply of the sterol was from liposomes. Figure 23). 
Cholesterol could diffuse through the aqueous medium, but desorption of the sterol from 
lipid bilayers and aqueous diffusion would be very slow considering the solubility of the 
sterol in aqueous solution. In pure water, solubility of cholesterol is 1.8 (ag/ml or 4.7 |iM 
[124]. Or, movement of the sterol between membranes could be promoted by collision or 
contact of ER membranes with liposomes, and the efficiency of cholesterol transfer from 
one bilayer to another may very well depend on the duration and distance of the contact 
and may not be high. Cholesterol transport inside the cell among different membrane 
compartments is proposed to proceed through three possible mechanisms: aqueous 
diffusion, vesicle-mediated transport, and soluble protein or lipid carriers. Vesicular 
transport and cytosolic carriers are most likely the major mechanisms [125,126]. Artificial 
vesicles like liposomes do not possess the property of the cellular vesicles in that the 
possible protein and lipid factors that mediate cellular lipid transfer between bilayers or 
vesicle-membrane fusion are not present, and so artificial vesicles may not function 
effectively in some cases of in vitro studies [88]. The access of cholesterol to the ACAT 
substrate pool had become a problem in the study of regulation of ACAT by the sterol and 
could only be overcome by the use a factor that can facilitate the access. In general, for 
processes that involve apolar molecules in aqueous media or reactions that have enzymes 
and substrates in different membrane compartments, transfer of non-polar molecules 
between membrane vesicles could be problematic and rate-limiting. The ability of 
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cyclodextrins to form inclusion complexes with lipophiles increases solubilities of non-polar 
molecules in aqueous solutions and enhances the transport and access of substrates to their 
enzymes. Cyclodextrins should be found more useful in situations where transfer of 
hydrophobic content between systems of membrane fragments is needed. 
To address the question how 25-OH activates ACAT in mammalian cells, the 
depleted microsomes of yolk sac membrane were assayed for ACAT activity with 
increasing concentration of cholesterol in the absence or presence of 25-OH and/or MpCD 
Figure 25). If the effect of 25-OH is on the access of cholesterol to ACAT, the addition 
of MpCD shoiild compromise and mask the effect of the oxysterol because both of them 
interact with the same activation mechanism. On the other hand, if 25-OH interacts with 
the enzyme directly, an increase in the activity by the addition of the oxysterol should be 
additive on top of the enhancement by the cyclodextrin because they affect different aspects 
of the enzyme catalysis. Surprisingly, 25-OH has no effect on ACAT activity in 
microsomes (Figtire 24) and in the depleted microsomes assayed with increasing 
concentration of cholesterol (Figure 25). No matter what it is in mammalian cells, the 
mechanism of ACAT activation by 25-OH is absent in the avian system. Another 
cholesterol oxidation product tested in the study, PCP-B, was shown to have a much smaller 
inhibitory effect on the avian enzyme, compared with that from mouse liver (Table 2). 
Apparently, ACAT of yolk sac membrane is different from its mammalian counterpart in 
that it is not very sensitive to influences of oxysterols. Considering the subtle differences 
in the function of the enzyme in the yolk sac membrane of fertilized eggs and in the liver, 
it is not unreasonble to see a high and sustained, rather than fluctuating and susceptible to 
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change, enzyme activity in such a vital and supportive tissue as the yolk sac membrane. 
Once the pure protein is available from both sources, a comparison of the structures will 
allow the identification of substrate binding sites, allosteric site(s), and possibly 25-OH 
interaction site, and the mechanism of oxysterol activation of ACAT can then be resolved. 
Like other oxysterols, 25-OH has been shown to form endogeneously and inhibit 
cholesterol biosynthesis through the rate-limiting enzyme HMG-CoA reductase in both 
whole animals and cultured cells of mammalian origin [72-74]. However, whether the 
regxilation of cholesterol homeostasis by oxysterols is physiologically relevant is not clear. 
It would be interesting to see if 25-OH has an effect on HMG-CoA reductase of yolk sac 
membrane and compare its sensitivity towards oxysterols with that of mammalian sources, 
although the de novo synthesis of cholesterol in the yolk sac membrane has not been 
reported and shown to be significant, and the activity of HMG-CoA reductase may not be 
high enough to be detectable. If the oxysterol has no effect on the enzyme from yolk sac 
membrane of chicken eggs after fertilization, it would be very interesting to see whether 
it has an effect on ACAT and HMG-CoA of mammalian source during embryogenesis and 
at the early stages of life. The formation and amounts of oxysterols have been shown to 
increase with pathogensis and aging [74], thus, the effect of cholesterol oxidation products 
on cholesterol metabolism may quite well be a chronic and adaptive result of the formation 
and accumulation of the oxidation products, and are not the original regulators of the 
metabolism. A life at its beginning, without oxidative accumulation, may lack the response 
to the oxysterols simply because they are physiologically irrelevant. 
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CHAPTER V. CONCLUSION 
Recent progress in molecular cloning of human macrophage ACAT has accelerated 
the process of ACAT investigation, however, study of the enzyme is still limited to 
microsomal preparations or detergent extracts due to lack of the homogenous protein. 
Having higher activity and better stability compared with the mammalian counterpart, 
ACAT from yolk sac membrane of chicken eggs 16 days after fertilization provides a good 
working system for the study of the critical enzyme in cholesteryl ester synthesis, which 
plays a very important role in the supply of lipid molecules as structural components and 
energy source during embryogenesis. The avian enzjane shares many common features 
with the manmialian equivalent, including catalytically related histidine(s) and cysteine(s), 
detergent extractable activity, and possible cooperative interaction of cholesterol with the 
enzyme. There are differences in the properties of the enzyme, though, between the avian 
and mammalian sources, and the most interesting one is the absence of any effect of 25-OH 
on the enzyme from yolk sac membrane. This disparity may reflect the subtle difference 
in the fimction of the enzyme under different physiological circumstances, or it may be the 
manifestation of an important question: whether cholesterol oxidation products are the 
initial regulators of sterol-mediated mechanism of cholesterol metabolism, or their effects 
are secondary and adaptive with the original signaling. Tests of 25-OH and probably other 
oxysterols on cholesterol biosynthesis pathway in yolk sac membrane of chicken eggs after 
fertilization and in mammalian system during embryogenesis and early stages of life, and 
on cholesterol esterification during mammalian embryo development would be worthy of 
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investigation. The oxysterols may turn out not to be the original regulators, but their 
accumulation with time make the cell adapt their effect. 
Redistribution of cholesterol among membrane fragments after the breakdown of the 
cell can lead to activation of ACAT since the enzyme is not saturated with the substrate 
under normal cellular conditions. Activation of ACAT during storage at 4°C is found 
unlikely to be due to destruction of any possible inhibitor(s) of ACAT existing in 
microsomal preparations, neither is it due to alteration in microsomal membrane structure 
induced by oxidation of membrane proteins and lipids and by addition of minor membrane 
lipids. The likelihood of any effect induced by second messengers is small. With the 
application of a cyclodextrin, which has the ability to form inclusion complexes with non-
polar molecules, the answer is pinpointed to be the consequence of cholesterol 
redistribution among lipid bilayers, leading to increased availability of substrate to the 
enzyme. Redistribution of cholesterol among membranes may happen quite commonly 
during experiments and may have caused some unexplainable phenomenon before. Lipid 
or protein factor(s) may exist and associate with cholesterol in the lipid bilayer, limiting 
complete random distribution/movement of the sterol in membranes and helping maintain 
microdomains of cholesterol-rich and -poor organizations. Sphingomyelin can be one of 
the factors that interact specifically with cholesterol, since cholesterol has been shown to 
have a high affinity with it. 
The use of MPCD in the study led to the recognition of cholesterol redistribution 
and made possible saturation of ACAT with cholesterol. The finding that cyclodextrins can 
enhance cholesterol transfer between liposomes and microsomes and eliminate the 8-
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limitation of slow movement of non-polar molecules in aqueous media should make them 
more useful in in vitro studies of apolar molecule transport between membrane vesicles. 
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